



(function() { var a=window,b="jstiming",d="tick";var
e=function(c){this.t={};this.tick=function(c,p,h){h=void 0!=h?h:(new
Date).getTime();this.t[c]=[h,p]};this[d]("start",null,c)},f=new
e;a.jstiming={Timer:e,load:f};if(a.performance&&a.performance.timing){var
g=a.performance.timing,j=a[b].load,k=g.navigationStart,l=g.responseStart;0<k&&l>=k&&(j[d]("_wtsrt",void
0,k),j[d]("wtsrt_","_wtsrt",l),j[d]("tbsd_","wtsrt_"))} try{var
m=null;a.chrome&&a.chrome.csi&&(m=Math.floor(a.chrome.csi().pageT),j&&0<k&&(j[d]("_tbnd",void
0,a.chrome.csi().startE),j[d]("tbnd_","_tbnd",k)));null==m&&a.gtbExternal&&(m=a.gtbExternal.pageT());null==m&&a.external&&(m=a.external.pageT,j&&0<k&&(j[d]("_tbnd",void
0,a.external.startE),j[d]("tbnd_","_tbnd",k)));m&&(a[b].pt=m)}catch(n){};a.tickAboveFold=function(c){var
i=0;if(c.offsetParent){do
i+=c.offsetTop;while(c=c.offsetParent)}c=i;750>=c&&a[b].load[d]("aft")};var
q=!1;function
r(){q||(q=!0,a[b].load[d]("firstScrollTime"))}a.addEventListener?a.addEventListener("scroll",r,!1):a.attachEvent("onscroll",r);
})(); April 2011 | Aids-Hiv <!-- /* /* Variable definitions ==================== <Variable
name="bgcolor" description="Page Background Color" type="color" default="#fff">
<Variable name="textcolor" description="Text Color" type="color" default="#333">
<Variable name="linkcolor" description="Link Color" type="color" default="#58a">
<Variable name="pagetitlecolor" description="Blog Title Color" type="color"
default="#666"> <Variable name="descriptioncolor" description="Blog Description
Color" type="color" default="#999"> <Variable name="titlecolor" description="Post
Title Color" type="color" default="#c60"> <Variable name="bordercolor"
description="Border Color" type="color" default="#ccc"> <Variable
name="sidebarcolor" description="Sidebar Title Color" type="color" default="#999">
<Variable name="sidebartextcolor" description="Sidebar Text Color" type="color"
default="#666"> <Variable name="visitedlinkcolor" description="Visited Link Color"
type="color" default="#999"> <Variable name="bodyfont" description="Text Font"
type="font" default="normal normal 100% Georgia, Serif"> <Variable name="headerfont"
description="Sidebar Title Font" type="font" default="normal normal 78% 'Trebuchet
MS',Trebuchet,Arial,Verdana,Sans-serif"> <Variable name="pagetitlefont"
description="Blog Title Font" type="font" default="normal normal 200% Georgia, Serif">
<Variable name="descriptionfont" description="Blog Description Font" type="font"
default="normal normal 78% 'Trebuchet MS', Trebuchet, Arial, Verdana, Sans-serif">
<Variable name="postfooterfont" description="Post Footer Font" type="font"
default="normal normal 78% 'Trebuchet MS', Trebuchet, Arial, Verdana, Sans-serif">
<Variable name="startSide" description="Side where text starts in blog language"
type="automatic" default="left"> <Variable name="endSide" description="Side where
text ends in blog language" type="automatic" default="right"> */ * Theme Name:
Diary/Notebook Author: Site5.com Author URI: http://gk.site5.com/t/312 Description:
Check <a href="http://wordpress.site5.net/diary/doc/">Diary/Notebook
Documentation</a> in case you need directions or get support from <a
href="http://forums.site5.com/forumdisplay.php?f=104">Forum</a>. */ /* HTML5
Boilerplate html5doctor.com Reset Stylesheet (Eric Meyer's Reset Reloaded + HTML5
baseline) v1.4 2009-07-27 | Authors: Eric Meyer & Richard Clark */ html, body, div, span,
object, iframe, h1, h2, h3, h4, h5, h6, p, blockquote, pre, abbr, address, cite, code, del,
dfn, em, img, ins, kbd, q, samp, small, strong, sub, sup, var, b, i, dl, dt, dd, ol, ul, li,
fieldset, form, label, legend, table, caption, tbody, tfoot, thead, tr, th, td, article,
aside, canvas, details, figcaption, figure, footer, header, hgroup, menu, nav, section,
summary, time, mark, audio, video { margin:0; padding:0; border:0; outline:0;
font-size:100%; vertical-align:baseline; background:transparent;} article, aside,
details, figcaption, figure, footer, header, hgroup, menu, nav, section { display:block;}
nav ul { list-style:none; } blockquote, q { quotes:none; } blockquote:before,
blockquote:after, q:before, q:after { content:''; content:none; } a { margin:0;
padding:0; font-size:100%; vertical-align:baseline; background:transparent; } ins {
background-color:#ff9; color:#000; text-decoration:none; } mark {
background-color:#ff9; color:#000; font-style:italic; font-weight:bold; } del {
text-decoration: line-through; } abbr[title], dfn[title] { border-bottom:1px dotted;
cursor:help; } table { border-collapse:collapse; border-spacing:0; } hr { display:block;
height:1px; border:0; border-top:1px solid #ccc; margin:1em 0; padding:0; } input, select
{ vertical-align:middle; } a { border-bottom: 1px dotted #BBBBBB; color: #333333;
text-decoration: none;} #navbar-iframe{height:0px; display:none} /* Pretty Photto
------------------------------------ */ div.light_rounded .pp_top .pp_left{
background:
url(http://3.bp.blogspot.com/-tlVuJHnvswI/Tn7dH0zITnI/AAAAAAAAAno/xxzyrfbv_so/s000/sprite.png)
-88px -53px no-repeat;} div.light_rounded .pp_top .pp_middle{background:#fff;}
div.light_rounded .pp_top .pp_right{background:
url(http://3.bp.blogspot.com/-tlVuJHnvswI/Tn7dH0zITnI/AAAAAAAAAno/xxzyrfbv_so/s000/sprite.png)
-110px -53px no-repeat;} div.light_rounded .pp_content .ppt{color:#000;}
div.light_rounded .pp_content_container .pp_left,div.light_rounded
.pp_content_container .pp_right{background:#fff;} div.light_rounded .pp_content{
background-color:#fff;} div.light_rounded .pp_next:hover{ background:
url(http://4.bp.blogspot.com/-TC_4EF7NzS8/Tn7dHx69FLI/AAAAAAAAAns/qaihNk6EEEU/s000/btnnext.png)
center right no-repeat;cursor: pointer;} div.light_rounded .pp_previous:hover{
background:
url(http://1.bp.blogspot.com/-y3aljWTkjfU/Tn7dIAe2LiI/AAAAAAAAAnw/CpFKKXY5q-A/s000/btnprevious.png)
center left no-repeat;cursor: pointer;} div.light_rounded .pp_expand{ background:
url(http://3.bp.blogspot.com/-tlVuJHnvswI/Tn7dH0zITnI/AAAAAAAAAno/xxzyrfbv_so/s000/sprite.png)
-31px -26px no-repeat;cursor: pointer;} div.light_rounded .pp_expand:hover{
background:
url(http://3.bp.blogspot.com/-tlVuJHnvswI/Tn7dH0zITnI/AAAAAAAAAno/xxzyrfbv_so/s000/sprite.png)
-31px -47px no-repeat;cursor: pointer;} div.light_rounded .pp_contract{ background:
url(http://3.bp.blogspot.com/-tlVuJHnvswI/Tn7dH0zITnI/AAAAAAAAAno/xxzyrfbv_so/s000/sprite.png)
0 -26px no-repeat;cursor: pointer;} div.light_rounded .pp_contract:hover{ background:
url(http://3.bp.blogspot.com/-tlVuJHnvswI/Tn7dH0zITnI/AAAAAAAAAno/xxzyrfbv_so/s000/sprite.png)
0 -47px no-repeat;cursor: pointer;} div.light_rounded .pp_close{
width:75px;height:22px;background:
url(http://3.bp.blogspot.com/-tlVuJHnvswI/Tn7dH0zITnI/AAAAAAAAAno/xxzyrfbv_so/s000/sprite.png)
-1px -1px no-repeat;cursor: pointer;} div.light_rounded #pp_full_res
.pp_inline{color:#000;} div.light_rounded .pp_arrow_previous{ background:
url(http://3.bp.blogspot.com/-tlVuJHnvswI/Tn7dH0zITnI/AAAAAAAAAno/xxzyrfbv_so/s000/sprite.png)
0 -71px no-repeat;} div.light_rounded
.pp_arrow_previous.disabled{background-position:0 -87px;cursor:default;}
div.light_rounded .pp_arrow_next{ background:
url(http://3.bp.blogspot.com/-tlVuJHnvswI/Tn7dH0zITnI/AAAAAAAAAno/xxzyrfbv_so/s000/sprite.png)
-22px -71px no-repeat;} div.light_rounded
.pp_arrow_next.disabled{background-position: -22px -87px;cursor:default;}
div.light_rounded .pp_bottom .pp_left{ background:
url(http://3.bp.blogspot.com/-tlVuJHnvswI/Tn7dH0zITnI/AAAAAAAAAno/xxzyrfbv_so/s000/sprite.png)
-88px -80px no-repeat;} div.light_rounded .pp_bottom .pp_middle{background:#fff;}
div.light_rounded .pp_bottom .pp_right{ background:
url(http://3.bp.blogspot.com/-tlVuJHnvswI/Tn7dH0zITnI/AAAAAAAAAno/xxzyrfbv_so/s000/sprite.png)
-110px -80px no-repeat;} div.light_rounded .pp_loaderIcon{background:
url(http://2.bp.blogspot.com/-MlPuE3gUH38/Tn7dIf2X7uI/AAAAAAAAAn0/ILu-Mux90gE/s000/loader.gif)
center center no-repeat;} div.pp_pic_holder a:focus{outline:none;} div.pp_overlay{
background:#000;display:
none;left:0;position:absolute;top:0;width:100%;z-index:9500;}
div.pp_pic_holder{display: none;position:absolute; width:100px;z-index:10000;}
.pp_top{height:20px;position: relative;} * html .pp_top{padding:0 20px;} .pp_top
.pp_left{height:20px;left:0;position:absolute;width:20px;} .pp_top
.pp_middle{height:20px;left:20px;position:absolute;right:20px;} * html .pp_top
.pp_middle{left:0;position: static;} .pp_top .pp_right{
height:20px;left:auto;position:absolute;right:0;top:0;width:20px;}
.pp_content{height:40px;} .pp_content .ppt{left:auto; margin-bottom:5px;position:
relative;top:auto;} .pp_fade{display: none;} .pp_content_container{position:
relative; text-align: left;width:100%;} .pp_content_container
.pp_left{padding-left:20px;} .pp_content_container .pp_right{padding-right:20px;}
.pp_content_container .pp_details{margin:10px 0 2px 0;} .pp_description{display:
none;margin:0 0 5px 0;} .pp_nav{clear: left;float: left;margin:3px 0 0 0;} .pp_nav
p{float: left;margin:2px 4px;} .pp_nav a.pp_arrow_previous,.pp_nav a.pp_arrow_next{
display:block;float: left;height:15px;margin-top:3px;overflow:
hidden;text-indent: -10000px;width:14px;}
.pp_hoverContainer{position:absolute;top:0;width:100%;z-index:2000;}
a.pp_next{background:
url(http://4.bp.blogspot.com/-TC_4EF7NzS8/Tn7dHx69FLI/AAAAAAAAAns/qaihNk6EEEU/s000/btnnext.png)
10000px 10000px no-repeat;display:block;float: right;height:100%; text-indent:
-10000px;width:49%;} a.pp_previous{ background:
url(http://4.bp.blogspot.com/-TC_4EF7NzS8/Tn7dHx69FLI/AAAAAAAAAns/qaihNk6EEEU/s000/btnnext.png)
10000px 10000px no-repeat;display:block;float: left;height:100%; text-indent:
-10000px;width:49%;} a.pp_expand,a.pp_contract{cursor: pointer; display:
none;height:20px;position:absolute;right:30px; text-indent:
-10000px;top:10px;width:20px; z-index:20000;} a.pp_close{display:block;float:
right; text-indent: -10000px;} .pp_bottom{height:20px;position: relative;} * html
.pp_bottom{padding:0 20px;} .pp_bottom
.pp_left{height:20px;left:0;position:absolute;width:20px;} .pp_bottom
.pp_middle{height:20px;left:20px;position:absolute;right:20px;} * html .pp_bottom
.pp_middle{left:0;position: static;} .pp_bottom .pp_right{
height:20px;left:auto;position:absolute;right:0;top:0;width:20px;}
.pp_loaderIcon{display:block;height:24px;left:50%; margin: -12px 0 0
-12px;position:absolute;top:50%;width:24px;} #pp_full_res{line-height:1
!important;} #pp_full_res .pp_inline{text-align: left;} #pp_full_res .pp_inline
p{margin:0 0 15px 0;} div.ppt{color:#fff;display:
none;font-size:17px;left:0;position:absolute;top:0;z-index:9999;}
.clearfix:after{content: ".";display:block;height:0;clear:both;visibility:
hidden;} .clearfix {display: inline-block;} * html .clearfix {height:1%;} .clearfix
{display:block;} /* End of Reset CSS */ body {
background:url(http://4.bp.blogspot.com/-N7CBPLyQy9c/Tn7dI0OluVI/AAAAAAAAAn4/VLYEZR-Mia4/s000/bk_body.png);
font-size:13px; font-family:Georgia,"Times New Roman", Times, serif;
line-height:20px; color:#333;} p {padding: 0 0 1.3em;} h1, h2 , h3, h4, h5, h6 {
display:block; color:#13382A; line-height:100%; font-family:Droid Serif, Georgia,
serif; text-shadow:1px 1px #fff;} h1 a, h2 a, h3 a, h4 a, h5 a, h6 a {text-decoration:none;} h1
{letter-spacing:-2px;} h2 { font-size:16px; margin:10px 0 15px; font-weight:bold; } a {
color:#333; border-bottom: 1px dotted #bbb; text-decoration:none; } a:hover {
color:#A3A30E; border-bottom: 1px dotted #A3A30E; } /* Header ---------------------- */
#header-wrapper {
background:url(http://2.bp.blogspot.com/-SOaF6ic6YCk/Tn7dJA_SBvI/AAAAAAAAAn8/I4H0xt_lKEo/s000/bk_header.png)
no-repeat; height:110px; padding:24px 50px 0 75px; position:relative;} #header-inner {
background-position: center; margin-left: auto; margin-right: auto;} #header { margin:
0px; color:#666666;} #header h1 { margin: 0px; font-family:Droid Serif, Georgia, serif;
font-weight:bold; font-size:30px; color:#0C211A; text-shadow:1px 1px #fff;
letter-spacing:-2px; padding:0; line-height:40px;} #header a { color:#666666;
text-decoration:none;border:none; } #header a:hover { color:#666666; } #header
.description { margin: 0px; padding:0px; font-size:10px; color:#666;
text-transform:uppercase; font-family:Arial, Helvetica, sans-serif; } #header img {
margin-left: auto; margin-right: auto;} #topSearch { position:absolute; right:50px;
top:50px;} #topSearch input[type="text"] { background:
url("http://1.bp.blogspot.com/-SPf1vl23pqc/Tn7dJVF6frI/AAAAAAAAAoA/l4cp88U2QLY/s000/ico_search.png")
no-repeat scroll 94% 50% #FFFFFF; border: medium none; border-radius: 12px 12px 12px 12px;
box-shadow: 1px 1px 2px #BBBBBB inset; color: #999999; font-family: Georgia,"Times New
Roman",Times,serif; font-size: 12px; font-style: italic; padding: 7px 10px; width:
220px;} input, select { vertical-align: middle;} #content-wrapper { margin: 0 auto; width:
922px;
background:url(http://1.bp.blogspot.com/-qibxgue371M/Tn7dJoDs1iI/AAAAAAAAAoE/LCSllkZwCY0/s000/bk_content_wrap.png)
0 10px repeat-y; overflow:hidden;} #content-inner-wrapper {
background:url(http://2.bp.blogspot.com/-eLsmA2vB-pg/Tn7dJ2orpAI/AAAAAAAAAoI/ZFEUcLLAVhs/s000/bk_content.png)
no-repeat; min-height:200px; overflow:hidden;} /* Outer-Wrapper
----------------------------------------- */ #outer-wrapper { width:922px;
margin:10px auto 0; padding:0px; text-align:left; font: normal normal 100% Georgia,
Serif; } #main-wrapper { float:left; width:480px; padding:20px 60px 20px 80px; word-wrap:
break-word; overflow: hidden; } #sidebar-wrapper { float:left; width:230px;
background:url(http://3.bp.blogspot.com/-wif6G8rOym8/Tn7dKdrGWqI/AAAAAAAAAoM/9RmQE1yFAuU/s000/shadow_social.png)
0 28px no-repeat; min-height:200px; padding-left:20px; font-size:12px; word-wrap:
break-word; overflow: hidden; } /* Posts ------------------- */ .date-header {
font-family:Kristi; font-weight:normal; font-size:26px; /*color:#EC9D00;*/
color:#666; text-shadow:1px 1px #fff; padding: 0px 5px 0px 0px; } .post { background:
url("http://3.bp.blogspot.com/-LvwmF-K_OH8/Tn7dKsKrpdI/AAAAAAAAAoQ/A1edUKu_cBg/s000/bk_post_header.png")
no-repeat scroll 78px 0 transparent; position: relative; } .post-header{ background:
url("http://1.bp.blogspot.com/-KXQMBiCn9PQ/Tn7dKkDADWI/AAAAAAAAAoU/oNsyL44OYz0/s000/bk_header_separator.png")
no-repeat scroll 50% 100% transparent; margin-bottom: 20px; overflow: hidden;
padding-bottom: 0; padding-top: 30px;} .post h3 { font-size:24px; font-family: Droid
Serif, Georgia, serif; font-weight:normal; padding:5px 0px; text-shadow:1px 1px #fff;}
.post h3 a, .post h3 a:visited, .post h3 strong { color:#13382A; border:none;} .post h3
strong, .post h3 a:hover { color:#B6BE10; border-bottom:1px dotted #B6BE10;}
.post-labels{ background:
url(http://2.bp.blogspot.com/-8pPce--3Zxw/Tn7dLNGV7zI/AAAAAAAAAoY/R4_zaeOU6nE/s000/ico_file.png)
no-repeat; padding-left: 22px; font-size:12px; font-style:italic;
font-family:Georgia, "Times New Roman", Times, serif;} .post-labels a
{text-decoration:none;} .post-body {
background:url(http://1.bp.blogspot.com/-KXQMBiCn9PQ/Tn7dKkDADWI/AAAAAAAAAoU/oNsyL44OYz0/s000/bk_header_separator.png)
50% 100% no-repeat; padding-bottom:10px; margin-bottom:20px; line-height:20px;}
.post-body p{ padding: 0 0 1.3em;} .post-body blockquote { line-height:1.3em; }
.post-footer { margin: .75em 0; color:#999999; letter-spacing:.1em; font: normal normal
78% 'Trebuchet MS', Trebuchet, Arial, Verdana, Sans-serif; line-height: 1.4em;}
.comment-link {margin-left:.6em;} .post img, table.tr-caption-container { background:
none repeat scroll 0 0 #F8F7F1; border: 1px solid #FFFFFF; box-shadow: 0 0 5px 2px #DDDDDD;
padding: 10px;} .post img:hover{ background:#FDFDFB; border:1px solid #8DDCEF;
-moz-box-shadow:0 0 10px 2px #B9E9F7; -webkit-box-shadow:0 0 10px 4px #B9E9F7;
box-shadow:0 0 10px 4px #B9E9F7;} .tr-caption-container img { border: none; padding: 0;}
.jump-link a{ font-family:Kristi; color:#B6BE10; font-size:26px;
text-decoration:none; border:none; } .jump-link a:hover { color:#333; text-shadow:1px
1px #fff;} .post .sidebadge, .page .sidebadge { background:
url("http://1.bp.blogspot.com/-5EWoVSowQ6s/Tn7dLS1JoxI/AAAAAAAAAoc/2s8Qeq3XLfg/s000/post_badge.png")
no-repeat scroll 0 0 transparent; height: 33px; left: -52px; position: absolute; top: 25px;
width: 42px; } /* PAGINATION */ .emm-paginate { overflow:hidden; text-align:center;;
font-size:16px; float:left; padding-right:2px; } .emm-paginate a, .emm-paginate
.emm-current { display:block; width:26px; height:20px; text-align:center;
text-decoration:none; float:left; padding-bottom:10px; border:none;} .emm-paginate
.emm-title { float:left; font-size:13px; color:#555; padding-top:3px;} .emm-paginate
.emm-gap { color:#999; margin-left:10px;} .emm-paginate .emm-current {
background:url(http://2.bp.blogspot.com/-NvNzwvCrSao/Tn7dLdxuL9I/AAAAAAAAAog/ZxK07Yf-nr8/s000/bk_pagination.png)
50% 100% no-repeat;} .emm-paginate .emm-page {} .emm-paginate .emm-prev, .emm-paginate
.emm-next {} /* Comments ----------------------------------------------- */ #comments
h4 { display:block;
background:url(http://1.bp.blogspot.com/-3S0OeGDMQvE/Tn7dLhifUnI/AAAAAAAAAok/UTnceA56_hg/s000/ico_comments.png)
0 50% no-repeat; padding:10px 0 10px 45px; margin:20px 0 0 0; } #comments-block { background:
url("http://1.bp.blogspot.com/-KXQMBiCn9PQ/Tn7dKkDADWI/AAAAAAAAAoU/oNsyL44OYz0/s000/bk_header_separator.png")
no-repeat scroll 50% 100% transparent; display: block; list-style: none outside none;
overflow: hidden; padding-bottom: 30px; } #comments-block .comment-author { font-style:
italic; } #comments-block .comment-body { margin:.25em 0 0;font-style: italic; }
#comments-block .comment-footer { margin:-.25em 0 2em; font-style: italic; margin-left:
60px; } #comments-block .comment-body p { margin: 5px 0; padding: 5px 0; font-style: italic;
} .deleted-comment { font-style:italic; color:gray; } #blog-pager-newer-link { float:
left; } #blog-pager-older-link { float: right; } #blog-pager { text-align: center; }
.feed-links { text-indent:-9999em;height:0px; } /* Sidebar Content
----------------------------------------------- */ .sidebar { margin:10px 0
20px;padding: 0px 0px; /*font-style:italic;*/ } .sidebar h2{ font-size:16px;
letter-spacing:-1px; margin-bottom:15px; font-style:normal; font-weight:normal;
color:#000;
/*background:url(http://4.bp.blogspot.com/-4z_3Ct1zqRQ/Tn7dLzXnYRI/AAAAAAAAAoo/aee9q4TDYQc/s000/bk_header_separator.png)
0 100% no-repeat;*/ padding-bottom:10px; border-bottom:1px dashed #B9B9B5; }
#socialIcons{ height: 90px; margin-bottom: 40px; margin-top: -22px; text-align: center;
} #socialIcons ul{ padding: 0px 0px 0px 6px; margin-bottom:8px; overflow:hidden;
text-align:center; } #socialIcons li {display:inline;} #socialIcons li a{
display:block; width:67px; height:46px; text-indent:-9999px; border:none;
float:left; } #socialIcons li a.twitter{
background:url(http://2.bp.blogspot.com/-x1p5ij3JhiU/Tn7dMJvLcrI/AAAAAAAAAos/7rmquWn5-ls/s000/ico_social_twitter.png)
0 0 no-repeat;} #socialIcons li a.facebook{
background:url(http://4.bp.blogspot.com/-rRy8A9piOfk/Tn7dMSpCxAI/AAAAAAAAAow/4vAVqFGU3Wk/s000/ico_social_facebook.png)
0 0 no-repeat;} #socialIcons li a.rss {
background:url(http://3.bp.blogspot.com/-MLlhQ8LXBKc/Tn7dMvEguZI/AAAAAAAAAo0/xFHSluRiJz0/s000/ico_social_rss.png)
0 0 no-repeat;} #socialIcons li a:hover {background-position:0 -46px;} #socialIcons
#butContact { display:block;
background:url(http://4.bp.blogspot.com/-2y8ZzqEz8AQ/Tn7dM4NDDjI/AAAAAAAAAo4/Fd5z01rnBXU/s000/ico_contact.png)
50% 0 no-repeat; text-indent:-9999px; border:none; height:29px; } /*#socialIcons
#butContact:hover {
background:url(http://4.bp.blogspot.com/-2y8ZzqEz8AQ/Tn7dM4NDDjI/AAAAAAAAAo4/Fd5z01rnBXU/s000/ico_contact.png)
50% -29px no-repeat; }*/ .sidebar ul { list-style-type:none;margin: 0px; padding:0px; }
.sidebar li { padding:4px 0;
background:url(http://2.bp.blogspot.com/-pvEFNTq-_3Q/Tn7dNNnBO7I/AAAAAAAAAo8/TKwfOhxNk4s/s000/bullet_star_pink.png)
0 9px no-repeat; padding-left:20px; } .sidebar li a { text-decoration:none; } .sidebar
.widget{ padding-left:10px; } .main .Blog { border-bottom-width: 0; } /**/ #twitter {
padding:0; margin:0; width: 100%; } #twitter h3{ font-size:16px; letter-spacing:-1px;
margin-bottom:15px; font-style:normal; font-weight:normal; color:#000; padding: 5px
0px 5px 13px; } #twitter ul{margin: 0px; padding: 0px 0px 0px 5px; list-style:none} #twitter
li { background:none; padding-left:0; font-size:11px; color:#666; border-bottom:1px
dotted #B9B9B5; padding-bottom:10px; margin:5px 0; font-style:italic;
list-style:none; } .tweet_list li a {list-style:none} .tweet_list li img { float:left;
padding:2px; background:#F8F7F1; border:1px solid #FFF; -moz-box-shadow:0 0 3px 2px
#ddd; -webkit-box-shadow:0 0 3px 2px #ddd; box-shadow:0 0 3px 2px #ddd; margin:0 10px 10px 0;
} .tweet_list li .tweet_time {font-size:10px;} .followTwitter { font-weight:bold;
color:#5599BB; } .followTwitter:hover{ border-bottom:1px dotted #5599BB; } /* Profile
----------------------------------------------- */ .profile-img { float: left;
margin-top: 0; margin-right: 5px; margin-bottom: 5px; margin-left: 0; padding: 4px;
border: 1px solid #cccccc; } .profile-data { margin:0; text-transform:uppercase;
letter-spacing:.1em; font: normal normal 78% 'Trebuchet MS', Trebuchet, Arial, Verdana,
Sans-serif; color: #999999; font-weight: bold; line-height: 1.6em; } .profile-datablock
{ margin:.5em 0 .5em; } .profile-textblock { margin: 0.5em 0; line-height: 1.6em; }
.profile-link { font: normal normal 78% 'Trebuchet MS', Trebuchet, Arial, Verdana,
Sans-serif; text-transform: uppercase; letter-spacing: .1em; } /* Footer
----------------------------------------------- */ #footer {
background:url(http://2.bp.blogspot.com/-1_6i-o6vFgU/Tn7dNsmn5uI/AAAAAAAAApE/e38WrrEkZRI/s000/bk_footer.png)
no-repeat; min-height:140px; padding: 0px; } #site5bottom { float:right; margin-top:
0px; margin-left:60px; line-height:130%; width:150px; text-align:right; } #pagefooter
{ color:#333; padding:70px 30px 0 50px; text-shadow:1px 1px #fff; font-size:12px; }
#pagefooter #html5 { float:right; margin-top:-5px; /*margin-right:100px;*/
font-size:11px; float:right; text-align:center; } #pagefooter #html5 a{ border:none; }
#pagefooter #html5 img { vertical-align:middle; } .post img {max-width: 99%;}
.blog-pager,#blog-pager{ overflow:hidden; text-align:center; font-size:15px;
float:left; padding-right:2px; } .showpageNum a,.showpage a { margin:0px 1px 0
1px;padding:3px 8px; text-decoration:none;border:0px solid;
color:#333;line-height:14px;cursor:pointer;white-space:nowrap; } .showpageNum
a:hover,.showpage a:hover { text-decoration:none;border:0px solid; } .showpageOf{
margin:0 8px 0 0; } .showpagePoint { background:transparent
url('http://2.bp.blogspot.com/-NvNzwvCrSao/Tn7dLdxuL9I/AAAAAAAAAog/ZxK07Yf-nr8/s000/bk_pagination.png')
50% 100% no-repeat; margin:0 3px 0 3px;padding:8px 8px;
line-height:14px;cursor:pointer;white-space:nowrap;
color:#333;text-decoration:none;font-weight:bold;border:0px solid; } -->
//<![CDATA[ (function($) { $.fn.tweet = function(o){ var s = $.extend({ username: null, //
[string or array] required unless using the 'query' option; one or more twitter screen names
list: null, // [string] optional name of list belonging to username favorites: false, //
[boolean] display the user's favorites instead of his tweets query: null, // [string]
optional search query avatar_size: null, // [integer] height and width of avatar if
displayed (48px max) count: 3, // [integer] how many tweets to display? fetch: null, //
[integer] how many tweets to fetch via the API (set this higher than 'count' if using the
'filter' option) retweets: true, // [boolean] whether to fetch (official) retweets (not
supported in all display modes) intro_text: null, // [string] do you want text BEFORE your
your tweets? outro_text: null, // [string] do you want text AFTER your tweets? join_text:
null, // [string] optional text in between date and tweet, try setting to "auto"
auto_join_text_default: "i said,", // [string] auto text for non verb: "i said" bullocks
auto_join_text_ed: "i", // [string] auto text for past tense: "i" surfed
auto_join_text_ing: "i am", // [string] auto tense for present tense: "i was" surfing
auto_join_text_reply: "i replied to", // [string] auto tense for replies: "i replied to"
@someone "with" auto_join_text_url: "i was looking at", // [string] auto tense for urls: "i
was looking at" http:... loading_text: null, // [string] optional loading text, displayed
while tweets load refresh_interval: null , // [integer] optional number of seconds after
which to reload tweets twitter_url: "twitter.com", // [string] custom twitter url, if any
(apigee, etc.) twitter_api_url: "api.twitter.com", // [string] custom twitter api url, if
any (apigee, etc.) twitter_search_url: "search.twitter.com", // [string] custom twitter
search url, if any (apigee, etc.) template: "{avatar}{time}{join}{text}", // [string or
function] template used to construct each tweet <li> - see code for available vars
comparator: function(tweet1, tweet2) { // [function] comparator used to sort tweets (see
Array.sort) return tweet2["tweet_time"] - tweet1["tweet_time"]; }, filter:
function(tweet) { // [function] whether or not to include a particular tweet (be sure to also
set 'fetch') return true; } }, o); $.fn.extend({ linkUrl: function() { var returning = []; //
See http://daringfireball.net/2010/07/improved_regex_for_matching_urls var regexp =
/\b((?:[a-z][\w-]+:(?:\/{1,3}|[a-z0-9%])|www\d{0,3}[.]|[a-z0-9.\-]+[.][a-z]{2,4}\/)(?:[^\s()<>]+|\(([^\s()<>]+|(\([^\s()<>]+\)))*\))+(?:\(([^\s()<>]+|(\([^\s()<>]+\)))*\)|[^\s`!()\[\]{};:'".,<>?ï¿œï¿œï¿œï¿œï¿œï¿œ]))/gi;
this.each(function() { returning.push(this.replace(regexp, function(match) { var url =
(/^[a-z]+:/i).test(match) ? match : "http://"+match; return "<a
href=\""+url+"\">"+match+"</a>"; })); }); return $(returning); }, linkUser: function()
{ var returning = []; var regexp = /[\@]+([A-Za-z0-9-_]+)/gi; this.each(function() {
returning.push(this.replace(regexp,"<a
href=\"http://"+s.twitter_url+"/$1\">@$1</a>")); }); return $(returning); },
linkHash: function() { var returning = []; var regexp = /(?:^| )[\#]+([A-Za-z0-9-_]+)/gi;
var usercond = s.username ? '&from='+s.username.join("%2BOR%2B") : '';
this.each(function() { returning.push(this.replace(regexp, ' <a
href="http://'+s.twitter_search_url+'/search?q=&tag=$1&lang=all'+usercond+'">#$1</a>'));
}); return $(returning); }, capAwesome: function() { var returning = [];
this.each(function() { returning.push(this.replace(/\b(awesome)\b/gi, '<span
class="awesome">$1</span>')); }); return $(returning); }, capEpic: function() { var
returning = []; this.each(function() { returning.push(this.replace(/\b(epic)\b/gi,
'<span class="epic">$1</span>')); }); return $(returning); }, makeHeart: function() {
var returning = []; this.each(function() {
returning.push(this.replace(/(&lt;)+[3]/gi, "<tt class='heart'>&#x2665;</tt>"));
}); return $(returning); } }); function parse_date(date_str) { // The non-search twitter
APIs return inconsistently-formatted dates, which Date.parse // cannot handle in IE. We
therefore perform the following transformation: // "Wed Apr 29 08:53:31 +0000 2009" => "Wed,
Apr 29 2009 08:53:31 +0000" return Date.parse(date_str.replace(/^([a-z]{3})( [a-z]{3}
\d\d?)(.*)( \d{4})$/i, '$1,$2$4$3')); } function relative_time(date) { var relative_to =
(arguments.length > 1) ? arguments[1] : new Date(); var delta =
parseInt((relative_to.getTime() - date) / 1000, 10); var r = ''; if (delta < 60) { r = delta + '
seconds ago'; } else if(delta < 120) { r = 'a minute ago'; }
el)[0].parentNode,n=b.createElement(se if(delta < (45*60)) { r = (parseInt(delta / 60,
10)).toString() + ' minutes ago'; } else if(delta < (2*60*60)) { r = 'an hour ago'; } else
if(delta < (24*60*60)) { r = '' + (parseInt(delta / 3600, 10)).toString() + ' hours ago'; } else
if(delta < (48*60*60)) { r = 'a day ago'; } else { r = (parseInt(delta / 86400, 10)).toString() +
' days ago'; } return 'about ' + r; } function build_url() { var proto = ('https:' ==
document.location.protocol ? 'https:' : 'http:'); var count = (s.fetch === null) ? s.count :
s.fetch; if (s.list) { return
proto+"//"+s.twitter_api_url+"/1/"+s.username[0]+"/lists/"+s.list+"/statuses.json?per_page="+count+"&callback=?";
} else if (s.favorites) { return
proto+"//"+s.twitter_api_url+"/favorites/"+s.username[0]+".json?count="+s.count+"&callback=?";
} else if (s.query === null && s.username.length == 1) { return
proto+'//'+s.twitter_api_url+'/1/statuses/user_timeline.json?screen_name='+s.username[0]+'&count='+count+(s.retweets
? '&include_rts=1' : '')+'&callback=?'; } else { var query = (s.query ||
'from:'+s.username.join(' OR from:')); return
proto+'//'+s.twitter_search_url+'/search.json?&q='+encodeURIComponent(query)+'&rpp='+count+'&callback=?';
} } return this.each(function(i, widget){ var list = $('<ul
class="tweet_list">').appendTo(widget); var intro = '<p
class="tweet_intro">'+s.intro_text+'</p>'; var outro = '<p
class="tweet_outro">'+s.outro_text+'</p>'; var loading = $('<p
class="loading">'+s.loading_text+'</p>'); if(s.username && typeof(s.username) ==
"string"){ s.username = [s.username]; } var expand_template = function(info) { if (typeof
s.template === "string") { var result = s.template; for(var key in info) { var val = info[key];
result = result.replace(new RegExp('{'+key+'}','g'), val === null ? '' : val); } return
result; } else return s.template(info); }; if (s.loading_text)
$(widget).append(loading); $(widget).bind("load", function(){
$.getJSON(build_url(), function(data){ if (s.loading_text) loading.remove(); if
(s.intro_text) list.before(intro); list.empty(); var tweets = $.map(data.results ||
data, function(item){ var join_text = s.join_text; // auto join text based on verb tense and
content if (s.join_text == "auto") { if (item.text.match(/^(@([A-Za-z0-9-_]+)) .*/i)) {
join_text = s.auto_join_text_reply; } else if
(item.text.match(/(^\w+:\/\/[A-Za-z0-9-_]+\.[A-Za-z0-9-_:%&\?\/.=]+) .*/i)) {
join_text = s.auto_join_text_url; } else if (item.text.match(/^((\w+ed)|just) .*/im)) {
join_text = s.auto_join_text_ed; } else if (item.text.match(/^(\w*ing) .*/i)) {
join_text = s.auto_join_text_ing; } else { join_text = s.auto_join_text_default; } } //
Basic building blocks for constructing tweet <li> using a template var screen_name =
item.from_user || item.user.screen_name; var source = item.source; var user_url =
"http://"+s.twitter_url+"/"+screen_name; var avatar_size = s.avatar_size; var
avatar_url = item.profile_image_url || item.user.profile_image_url; var tweet_url =
"http://"+s.twitter_url+"/"+screen_name+"/statuses/"+item.id_str; var retweet =
(typeof(item.retweeted_status) != 'undefined'); var retweeted_screen_name = retweet ?
item.retweeted_status.user.screen_name : null; var tweet_time =
parse_date(item.created_at); var tweet_relative_time = relative_time(tweet_time);
var tweet_raw_text = retweet ? ('RT @'+retweeted_screen_name+'
'+item.retweeted_status.text) : item.text; // avoid '...' in long retweets var tweet_text
= $([tweet_raw_text]).linkUrl().linkUser().linkHash()[0]; // Default spans, and
pre-formatted blocks for common layouts var user = '<a class="tweet_user"
href="'+user_url+'">'+screen_name+'</a>'; var join = ((s.join_text) ? ('<span
class="tweet_join"> '+join_text+' </span>') : ' '); var avatar = (avatar_size ? ('<a
class="tweet_avatar" href="'+user_url+'"><img src="'+avatar_url+ '"
height="'+avatar_size+'" width="'+avatar_size+ '" alt="'+screen_name+'\'s avatar"
title="'+screen_name+'\'s avatar" border="0"/></a>') : ''); var time = '<span
class="tweet_time"><a href="'+tweet_url+'" title="view tweet on
twitter">'+tweet_relative_time+'</a></span>'; var text = '<span
class="tweet_text">'+$([tweet_text]).makeHeart().capAwesome().capEpic()[0]+
'</span>'; return { item: item, // For advanced users who want to dig out other info
screen_name: screen_name, user_url: user_url, avatar_size: avatar_size, avatar_url:
avatar_url, source: source, tweet_url: tweet_url, tweet_time: tweet_time,
tweet_relative_time: tweet_relative_time, tweet_raw_text: tweet_raw_text,
tweet_text: tweet_text, retweet: retweet, retweeted_screen_name:
retweeted_screen_name, user: user, join: join, avatar: avatar, time: time, text: text };
}); tweets = $.grep(tweets, s.filter).slice(0, s.count);
list.append($.map(tweets.sort(s.comparator), function(t) { return "<li>" +
expand_template(t) + "</li>"; }).join('')).
children('li:first').addClass('tweet_first').end().
children('li:odd').addClass('tweet_even').end().
children('li:even').addClass('tweet_odd'); if (s.outro_text) list.after(outro);
$(widget).trigger("loaded").trigger((tweets.length === 0 ? "empty" : "full")); if
(s.refresh_interval) { window.setTimeout(function() { $(widget).trigger("load"); },
1000 * s.refresh_interval); } }); }).trigger("load"); }); }; })(jQuery); //]]>
//<![CDATA[ /*
------------------------------------------------------------------------ * Class:
prettyPhoto * Use: Lightbox clone for jQuery * Author: Stephane Caron
(http://www.no-margin-for-errors.com) * Version: 2.5.6
------------------------------------------------------------------------- */
(function($){$.prettyPhoto={version:'2.5.6'};$.fn.prettyPhoto=function(settings){settings=jQuery.extend({animationSpeed:'normal',opacity:0.80,showTitle:true,allowresize:true,default_width:500,default_height:344,counter_separator_label:'/',theme:'light_rounded',hideflash:false,wmode:'opaque',autoplay:true,modal:false,changepicturecallback:function(){},callback:function(){},markup:'<div
class="pp_pic_holder"> \ <div class="pp_top"> \ <div class="pp_left"></div> \ <div
class="pp_middle"></div> \ <div class="pp_right"></div> \ </div> \ <div
class="pp_content_container"> \ <div class="pp_left"> \ <div class="pp_right"> \ <div
class="pp_content"> \ <div class="pp_loaderIcon"></div> \ <div class="pp_fade"> \ <a
href="#" class="pp_expand" title="Expand the image">Expand</a> \ <div
class="pp_hoverContainer"> \ <a class="pp_next" href="#">next</a> \ <a
class="pp_previous" href="#">previous</a> \ </div> \ <div id="pp_full_res"></div> \
<div class="pp_details clearfix"> \ <a class="pp_close" href="#">Close</a> \ <p
class="pp_description"></p> \ <div class="pp_nav"> \ <a href="#"
class="pp_arrow_previous">Previous</a> \ <p class="currentTextHolder">0/0</p> \ <a
href="#" class="pp_arrow_next">Next</a> \ </div> \ </div> \ </div> \ </div> \ </div> \
</div> \ </div> \ <div class="pp_bottom"> \ <div class="pp_left"></div> \ <div
class="pp_middle"></div> \ <div class="pp_right"></div> \ </div> \ </div> \ <div
class="pp_overlay"></div> \ <div class="ppt"></div>',image_markup:'<img
id="fullResImage" src="" />',flash_markup:'<object
classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" width="{width}"
height="{height}"><param name="wmode" value="{wmode}" /><param
name="allowfullscreen" value="true" /><param name="allowscriptaccess"
value="always" /><param name="movie" value="{path}" /><embed src="{path}"
type="application/x-shockwave-flash" allowfullscreen="true"
allowscriptaccess="always" width="{width}" height="{height}"
wmode="{wmode}"></embed></object>',quicktime_markup:'<object
classid="clsid:02BF25D5-8C17-4B23-BC80-D3488ABDDC6B"
codebase="http://www.apple.com/qtactivex/qtplugin.cab" height="{height}"
width="{width}"><param name="src" value="{path}"><param name="autoplay"
value="{autoplay}"><param name="type" value="video/quicktime"><embed src="{path}"
height="{height}" width="{width}" autoplay="{autoplay}" type="video/quicktime"
pluginspage="http://www.apple.com/quicktime/download/"></embed></object>',iframe_markup:'<iframe
src ="{path}" width="{width}" height="{height}"
frameborder="no"></iframe>',inline_markup:'<div class="pp_inline
clearfix">{content}</div>'},settings);if($.browser.msie&&parseInt($.browser.version)==6){settings.theme="light_square";}
if($('.pp_overlay').size()==0)_buildOverlay();var
doresize=true,percentBased=false,correctSizes,$pp_pic_holder,$ppt,$pp_overlay,pp_contentHeight,pp_contentWidth,pp_containerHeight,pp_containerWidth,windowHeight=$(window).height(),windowWidth=$(window).width(),setPosition=0,scrollPos=_getScroll();$(window).scroll(function(){scrollPos=_getScroll();_centerOverlay();_resizeOverlay();});$(window).resize(function(){_centerOverlay();_resizeOverlay();});$(document).keydown(function(e){if($pp_pic_holder.is(':visible'))
switch(e.keyCode){case 37:$.prettyPhoto.changePage('previous');break;case
39:$.prettyPhoto.changePage('next');break;case 27:if(!settings.modal)
$.prettyPhoto.close();break;};});$(this).each(function(){$(this).bind('click',function(){_self=this;theRel=$(this).attr('rel');galleryRegExp=/\[(?:.*)\]/;theGallery=galleryRegExp.exec(theRel);var
images=new Array(),titles=new Array(),descriptions=new
Array();if(theGallery){$('a[rel*='+theGallery+']').each(function(i){if($(this)[0]===$(_self)[0])setPosition=i;images.push($(this).attr('href'));titles.push($(this).find('img').attr('alt'));descriptions.push($(this).attr('title'));});}else{images=$(this).attr('href');titles=($(this).find('img').attr('alt'))?$(this).find('img').attr('alt'):'';descriptions=($(this).attr('title'))?$(this).attr('title'):'';}
$.prettyPhoto.open(images,titles,descriptions);return
false;});});$.prettyPhoto.open=function(gallery_images,gallery_titles,gallery_descriptions){if($.browser.msie&&$.browser.version==6){$('select').css('visibility','hidden');};if(settings.hideflash)$('object,embed').css('visibility','hidden');images=$.makeArray(gallery_images);titles=$.makeArray(gallery_titles);descriptions=$.makeArray(gallery_descriptions);image_set=($(images).size()>0)?true:false;_checkPosition($(images).size());$('.pp_loaderIcon').show();$pp_overlay.show().fadeTo(settings.animationSpeed,settings.opacity);$pp_pic_holder.find('.currentTextHolder').text((setPosition+1)+settings.counter_separator_label+$(images).size());if(descriptions[setPosition]){$pp_pic_holder.find('.pp_description').show().html(unescape(descriptions[setPosition]));}else{$pp_pic_holder.find('.pp_description').hide().text('');};if(titles[setPosition]&&settings.showTitle){hasTitle=true;$ppt.html(unescape(titles[setPosition]));}else{hasTitle=false;};movie_width=(parseFloat(grab_param('width',images[setPosition])))?grab_param('width',images[setPosition]):settings.default_width.toString();movie_height=(parseFloat(grab_param('height',images[setPosition])))?grab_param('height',images[setPosition]):settings.default_height.toString();if(movie_width.indexOf('%')!=-1||movie_height.indexOf('%')!=-1){movie_height=parseFloat(($(window).height()*parseFloat(movie_height)/100)-100);movie_width=parseFloat(($(window).width()*parseFloat(movie_width)/100)-100);percentBased=true;}
$pp_pic_holder.fadeIn(function(){imgPreloader="";switch(_getFileType(images[setPosition])){case'image':imgPreloader=new
Image();nextImage=new
Image();if(image_set&&setPosition>$(images).size())nextImage.src=images[setPosition+1];prevImage=new
Image();if(image_set&&images[setPosition-1])prevImage.src=images[setPosition-1];$pp_pic_holder.find('#pp_full_res')[0].innerHTML=settings.image_markup;$pp_pic_holder.find('#fullResImage').attr('src',images[setPosition]);imgPreloader.onload=function(){correctSizes=_fitToViewport(imgPreloader.width,imgPreloader.height);_showContent();};imgPreloader.onerror=function(){alert('Image
cannot be loaded. Make sure the path is correct and image
exist.');$.prettyPhoto.close();};imgPreloader.src=images[setPosition];break;case'youtube':correctSizes=_fitToViewport(movie_width,movie_height);movie='http://www.youtube.com/v/'+grab_param('v',images[setPosition]);if(settings.autoplay)movie+="&autoplay=1";toInject=settings.flash_markup.replace(/{width}/g,correctSizes['width']).replace(/{height}/g,correctSizes['height']).replace(/{wmode}/g,settings.wmode).replace(/{path}/g,movie);break;case'vimeo':correctSizes=_fitToViewport(movie_width,movie_height);movie_id=images[setPosition];movie='http://vimeo.com/moogaloop.swf?clip_id='+movie_id.replace('http://vimeo.com/','');if(settings.autoplay)movie+="&autoplay=1";toInject=settings.flash_markup.replace(/{width}/g,correctSizes['width']).replace(/{height}/g,correctSizes['height']).replace(/{wmode}/g,settings.wmode).replace(/{path}/g,movie);break;case'quicktime':correctSizes=_fitToViewport(movie_width,movie_height);correctSizes['height']+=15;correctSizes['contentHeight']+=15;correctSizes['containerHeight']+=15;toInject=settings.quicktime_markup.replace(/{width}/g,correctSizes['width']).replace(/{height}/g,correctSizes['height']).replace(/{wmode}/g,settings.wmode).replace(/{path}/g,images[setPosition]).replace(/{autoplay}/g,settings.autoplay);break;case'flash':correctSizes=_fitToViewport(movie_width,movie_height);flash_vars=images[setPosition];flash_vars=flash_vars.substring(images[setPosition].indexOf('flashvars')+10,images[setPosition].length);filename=images[setPosition];filename=filename.substring(0,filename.indexOf('?'));toInject=settings.flash_markup.replace(/{width}/g,correctSizes['width']).replace(/{height}/g,correctSizes['height']).replace(/{wmode}/g,settings.wmode).replace(/{path}/g,filename+'?'+flash_vars);break;case'iframe':correctSizes=_fitToViewport(movie_width,movie_height);frame_url=images[setPosition];frame_url=frame_url.substr(0,frame_url.indexOf('iframe')-1);toInject=settings.iframe_markup.replace(/{width}/g,correctSizes['width']).replace(/{height}/g,correctSizes['height']).replace(/{path}/g,frame_url);break;case'inline':myClone=$(images[setPosition]).clone().css({'width':settings.default_width}).wrapInner('<div
id="pp_full_res"><div class="pp_inline
clearfix"></div></div>').appendTo($('body'));correctSizes=_fitToViewport($(myClone).width(),$(myClone).height());$(myClone).remove();toInject=settings.inline_markup.replace(/{content}/g,$(images[setPosition]).html());break;};if(!imgPreloader){$pp_pic_holder.find('#pp_full_res')[0].innerHTML=toInject;_showContent();};});};$.prettyPhoto.changePage=function(direction){if(direction=='previous'){setPosition--;if(setPosition<0){setPosition=0;return;};}else{if($('.pp_arrow_next').is('.disabled'))return;setPosition++;};if(!doresize)doresize=true;_hideContent(function(){$.prettyPhoto.open(images,titles,descriptions)});$('a.pp_expand,a.pp_contract').fadeOut(settings.animationSpeed);};$.prettyPhoto.close=function(){$pp_pic_holder.find('object,embed').css('visibility','hidden');$('div.pp_pic_holder,div.ppt,.pp_fade').fadeOut(settings.animationSpeed);$pp_overlay.fadeOut(settings.animationSpeed,function(){$('#pp_full_res').html('');$pp_pic_holder.attr('style','').find('div:not(.pp_hoverContainer)').attr('style','');_centerOverlay();if($.browser.msie&&$.browser.version==6){$('select').css('visibility','visible');};if(settings.hideflash)$('object,embed').css('visibility','visible');setPosition=0;settings.callback();});doresize=true;};_showContent=function(){$('.pp_loaderIcon').hide();projectedTop=scrollPos['scrollTop']+((windowHeight/2)-(correctSizes['containerHeight']/2));if(projectedTop<0)projectedTop=0+$ppt.height();$pp_pic_holder.find('.pp_content').animate({'height':correctSizes['contentHeight']},settings.animationSpeed);$pp_pic_holder.animate({'top':projectedTop,'left':(windowWidth/2)-(correctSizes['containerWidth']/2),'width':correctSizes['containerWidth']},settings.animationSpeed,function(){$pp_pic_holder.find('.pp_hoverContainer,#fullResImage').height(correctSizes['height']).width(correctSizes['width']);$pp_pic_holder.find('.pp_fade').fadeIn(settings.animationSpeed);if(image_set&&_getFileType(images[setPosition])=="image"){$pp_pic_holder.find('.pp_hoverContainer').show();}else{$pp_pic_holder.find('.pp_hoverContainer').hide();}
if(settings.showTitle&&hasTitle){$ppt.css({'top':$pp_pic_holder.offset().top-25,'left':$pp_pic_holder.offset().left+20,'display':'none'});$ppt.fadeIn(settings.animationSpeed);};if(correctSizes['resized'])$('a.pp_expand,a.pp_contract').fadeIn(settings.animationSpeed);settings.changepicturecallback();});};function
_hideContent(callback){$pp_pic_holder.find('#pp_full_res object,#pp_full_res
embed').css('visibility','hidden');$pp_pic_holder.find('.pp_fade').fadeOut(settings.animationSpeed,function(){$('.pp_loaderIcon').show();if(callback)callback();});$ppt.fadeOut(settings.animationSpeed);}
function
_checkPosition(setCount){if(setPosition==setCount-1){$pp_pic_holder.find('a.pp_next').css('visibility','hidden');$pp_pic_holder.find('a.pp_arrow_next').addClass('disabled').unbind('click');}else{$pp_pic_holder.find('a.pp_next').css('visibility','visible');$pp_pic_holder.find('a.pp_arrow_next.disabled').removeClass('disabled').bind('click',function(){$.prettyPhoto.changePage('next');return
false;});};if(setPosition==0){$pp_pic_holder.find('a.pp_previous').css('visibility','hidden');$pp_pic_holder.find('a.pp_arrow_previous').addClass('disabled').unbind('click');}else{$pp_pic_holder.find('a.pp_previous').css('visibility','visible');$pp_pic_holder.find('a.pp_arrow_previous.disabled').removeClass('disabled').bind('click',function(){$.prettyPhoto.changePage('previous');return
false;});};if(setCount>1){$('.pp_nav').show();}else{$('.pp_nav').hide();}};function
_fitToViewport(width,height){hasBeenResized=false;_getDimensions(width,height);imageWidth=width;imageHeight=height;if(((pp_containerWidth>windowWidth)||(pp_containerHeight>windowHeight))&&doresize&&settings.allowresize&&!percentBased){hasBeenResized=true;notFitting=true;while(notFitting){if((pp_containerWidth>windowWidth)){imageWidth=(windowWidth-200);imageHeight=(height/width)*imageWidth;}else
if((pp_containerHeight>windowHeight)){imageHeight=(windowHeight-200);imageWidth=(width/height)*imageHeight;}else{notFitting=false;};pp_containerHeight=imageHeight;pp_containerWidth=imageWidth;};_getDimensions(imageWidth,imageHeight);};return{width:Math.floor(imageWidth),height:Math.floor(imageHeight),containerHeight:Math.floor(pp_containerHeight),containerWidth:Math.floor(pp_containerWidth)+40,contentHeight:Math.floor(pp_contentHeight),contentWidth:Math.floor(pp_contentWidth),resized:hasBeenResized};};function
_getDimensions(width,height){width=parseFloat(width);height=parseFloat(height);$pp_details=$pp_pic_holder.find('.pp_details');$pp_details.width(width);detailsHeight=parseFloat($pp_details.css('marginTop'))+parseFloat($pp_details.css('marginBottom'));$pp_details=$pp_details.clone().appendTo($('body')).css({'position':'absolute','top':-10000});detailsHeight+=$pp_details.height();detailsHeight=(detailsHeight<=34)?36:detailsHeight;if($.browser.msie&&$.browser.version==7)detailsHeight+=8;$pp_details.remove();pp_contentHeight=height+detailsHeight;pp_contentWidth=width;pp_containerHeight=pp_contentHeight+$ppt.height()+$pp_pic_holder.find('.pp_top').height()+$pp_pic_holder.find('.pp_bottom').height();pp_containerWidth=width;}
function
_getFileType(itemSrc){if(itemSrc.match(/youtube\.com\/watch/i)){return'youtube';}else
if(itemSrc.match(/vimeo\.com/i)){return'vimeo';}else
if(itemSrc.indexOf('.mov')!=-1){return'quicktime';}else
if(itemSrc.indexOf('.swf')!=-1){return'flash';}else
if(itemSrc.indexOf('iframe')!=-1){return'iframe'}else
if(itemSrc.substr(0,1)=='#'){return'inline';}else{return'image';};};function
_centerOverlay(){if(doresize){titleHeight=$ppt.height();contentHeight=$pp_pic_holder.height();contentwidth=$pp_pic_holder.width();projectedTop=(windowHeight/2)+scrollPos['scrollTop']-((contentHeight+titleHeight)/2);$pp_pic_holder.css({'top':projectedTop,'left':(windowWidth/2)+scrollPos['scrollLeft']-(contentwidth/2)});$ppt.css({'top':projectedTop-titleHeight,'left':(windowWidth/2)+scrollPos['scrollLeft']-(contentwidth/2)+20});};};function
_getScroll(){if(self.pageYOffset){return{scrollTop:self.pageYOffset,scrollLeft:self.pageXOffset};}else
if(document.documentElement&&document.documentElement.scrollTop){return{scrollTop:document.documentElement.scrollTop,scrollLeft:document.documentElement.scrollLeft};}else
if(document.body){return{scrollTop:document.body.scrollTop,scrollLeft:document.body.scrollLeft};};};function
_resizeOverlay(){windowHeight=$(window).height();windowWidth=$(window).width();$pp_overlay.css({'height':$(document).height()});};function
_buildOverlay(){$('body').append(settings.markup);$pp_pic_holder=$('.pp_pic_holder');$ppt=$('.ppt');$pp_overlay=$('div.pp_overlay');$pp_pic_holder.attr('class','pp_pic_holder
'+settings.theme);$pp_overlay.css({'opacity':0,'height':$(document).height()}).bind('click',function(){if(!settings.modal)
$.prettyPhoto.close();});$('a.pp_close').bind('click',function(){$.prettyPhoto.close();return
false;});$('a.pp_expand').bind('click',function(){$this=$(this);if($this.hasClass('pp_expand')){$this.removeClass('pp_expand').addClass('pp_contract');doresize=false;}else{$this.removeClass('pp_contract').addClass('pp_expand');doresize=true;};_hideContent(function(){$.prettyPhoto.open(images,titles,descriptions)});$pp_pic_holder.find('.pp_fade').fadeOut(settings.animationSpeed);return
false;});$pp_pic_holder.find('.pp_previous,
.pp_arrow_previous').bind('click',function(){$.prettyPhoto.changePage('previous');return
false;});$pp_pic_holder.find('.pp_next,
.pp_arrow_next').bind('click',function(){$.prettyPhoto.changePage('next');return
false;});};_centerOverlay();};function
grab_param(name,url){name=name.replace(/[\[]/,"\\\[").replace(/[\]]/,"\\\]");var
regexS="[\\?&]"+name+"=([^&#]*)";var regex=new RegExp(regexS);var
results=regex.exec(url);if(results==null) return"";else return
results[1];}})(jQuery); //]]> //<![CDATA[ $(document).ready(function(){
$('#butContact').mouseover(function(){ $(this).hide();
$(this).css('background-position','50% -29px'); $(this).fadeIn('normal'); });
$('#butContact').mouseout(function(){ $(this).hide();
$(this).css('background-position','50% 0'); $(this).fadeIn('normal'); }); // PRETTY
PHOTO INIT $("a[rel^='prettyPhoto']").prettyPhoto(); }); //]]> var
a=navigator,b="userAgent",c="indexOf",f="&m=1",g="(^|&)m=",h="?",i="?m=1";function
j(){var d=window.location.href,e=d.split(h);switch(e.length){case 1:return
d+i;case 2:return 0<=e[1].search(g)?null:d+f;default:return
null}}if(-1!=a[b][c]("Mobile")&&-1!=a[b][c]("WebKit")&&-1==a[b][c]("iPad")||-1!=a[b][c]("Opera
Mini")||-1!=a[b][c]("IEMobile")){var k=j();k&&window.location.replace(k)}; if
(window.jstiming) window.jstiming.load.tick('headEnd');

function setAttributeOnload(object, attribute, val) { if(window.addEventListener) {
window.addEventListener('load', function(){ object[attribute] = val; }, false); } else {
window.attachEvent('onload', function(){ object[attribute] = val; }); } }
gapi.load("iframes-styles-bubble", function() { if (window.iframes && iframes.open) {
iframes.open(
'//www.blogger.com/navbar.g?targetBlogID\75985826546147455418\46blogName\75Aids-Hiv\46publishMode\75PUBLISH_MODE_BLOGSPOT\46navbarType\75LIGHT\46layoutType\75LAYOUTS\46searchRoot\75http://aids-hivdisease.blogspot.com/search\46blogLocale\75en_GB\46v\0752\46homepageUrl\75http://aids-hivdisease.blogspot.com/\46vt\75-182877546433266714',
{ container: "navbar-iframe-container", id: "navbar-iframe" }, { }); } }); (function() {
var script = document.createElement('script'); script.type = 'text/javascript';
script.src = '//pagead2.googlesyndication.com/pagead/js/google_top_exp.js'; var
head = document.getElementsByTagName('head')[0]; if (head) {
head.appendChild(script); }})();

Aids-Hiv



var ultimaFecha = 'Thursday, 21 April 2011'; Thursday, 21 April 2011 0 comments

AIDS About childs



Image:
http://3.bp.blogspot.com/-6w4EvdvOtRE/Ta_a0sBRJuI/AAAAAAAAAFw/UUjhpe8uhDE/s1600/aids-orphan.gif

Image:
http://4.bp.blogspot.com/-pEzt4lAxths/Ta_a40nLlHI/AAAAAAAAAF0/6pGX0Dh6-wY/s320/aids3.jpg



Image:
http://2.bp.blogspot.com/-rCnM5MsQgBs/Ta_acb_0F2I/AAAAAAAAAFs/qeAHzu2MB0M/s1600/Stop-AIDS-Hand.gif



Image:
http://4.bp.blogspot.com/-ntoiqlV-Mz0/Ta_a_3NmW9I/AAAAAAAAAF4/8I2zll6vi9w/s320/hiv-aids-south-africa-large.jpg





Posted by Sheraz at 00:22

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif <!--
google_ad_client="pub-9292059858425752"; google_ad_host="pub-1556223355139109";
google_ad_width=300; google_ad_height=250; google_ad_format="300x250_as";
google_ad_type="text_image"; google_ad_host_channel="0001+S0009+L0007";
google_color_border="FFFFFF"; google_color_bg="FFFFFF";
google_color_link="333333"; google_color_url="000000";
google_color_text="3366CC"; //--> document.write(ultimaFecha); 0 comments

The Age of AIDS.



Image:
http://3.bp.blogspot.com/-Jcg6-mFn5WA/Ta_YyrmcoAI/AAAAAAAAAFo/K_05fDm8doA/s400/pk.jpg

Pakistan is a country on the brink of a major AIDS epidemic, and experts say "time is of the
essence" if this country of 159 million is to avoid following in the footsteps of neighboring
India, which has the world's second largest number of HIV/AIDS cases. Rising poverty, a
growing number of intravenous drug users, severe social stigma, and an absence of basic sex
education combine to make Pakistan particularly vulnerable. Although the recorded number
of infections is under 3,000, UNAIDS believes the number to be closer to 73,000 and rising. "We
are not actually diagnosing people," Dr. Asif Mirza of the Family Planning Association of
Pakistan told the BBC. "... And the people who are already diagnosed, we don't look after them
properly." HIV testing remains expensive, and the cost of antiretroviral treatment, at $300
per month, is nearly twice the average person's salary. Meanwhile, the country lacks the
basic central infrastructure to administer testing and treatment; health care is the
responsibility of provincial governments -- and even blood donations are not universally
screened for HIV. Religion dominates every aspect of life in Pakistan, where AIDS is seen
largely as divine retribution for immorality, but some non-governmental organizations
have found that by working with the religious community they can promote a basic
understanding of the disease and reduce its stigma. Amal, an NGO based in Islamabad, and
Catholic Relief Services have operated programs in several madrassas that encourage future
clerics to educate their worshipers about how the disease is spread and preach compassion for
the infected by drawing on teachings from the Qu'ran. However, most Muslim clerics remain
averse to teaching basic sex education -- particularly the use of condoms, which they argue
promotes promiscuity. The government of Pakistan recognizes the looming threat and has made
HIV/AIDS education an optional extracurricular program in the country's high schools, but
safe sex is not widely practiced here, even among the most at-risk groups. A survey of female
sex workers in Karachi found that one in five cannot recognize a condom and 75 percent do not
know condoms prevent HIV; one third had never even heard of AIDS. Intravenous drug users are
similarly uninformed, and they account for 74 percent of known transmissions. Small,
localized epidemics have already broken out among intravenous drug users in the cities of
Karachi and Lakarna, where HIV infection rates are 23 percent and 10 percent respectively.
For Pakistan, the time to prevent an epidemic may be running out.







Posted by Sheraz at 00:12

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif
document.write(ultimaFecha); 0 comments

Karachi Has More Than 100,000 Prostitutes

Shumaila is one of the rare ones who are aware about the perils of HIV/AIDS an thus insist upon
using condoms.  Hundreds of thousands of condoms have been distributed to sex workers  in
the last two years, which have saved them from being infected with the lethal virus. Karachi
has up to 100,000 female sex workers , according to data gathered by Pakistan Society, a local
welfare organisation. ‘This is 20 percent of their overall population in Pakistan. Lahore
comes next with 75,000 sex workers ,’ Saleem Azam, head of the charity. Prostitution may be
illegal but it has prospered in Pakistan, where an economic downturn and widening poverty
have forced women and men onto the streets to meet the rising cost of living . Shaheena, 38, is a
home-based sex worker. She is a skilled paramedic but seldom finds a permanent job. ‘So I
opted to enter this business on the side,’ she said, veiling her face to hide her identity.
‘I have sibblings, cousins, nephews and nieces who don’t know about my second
profession. So I don’t want to identify myself to embarass them. ‘But it’s a question of
survival as none of my relatives support me with money. They are all too stretched
themselves,’ she said. More than 60 percent of Pakistan’s prostitutes work from homes or
ply the streets, while the elite serve wealthy clients from kothikhanas (houses or rooms) in
plush neighbourhoods . A report said 60 percent of female sex workers and 45 percent of their
male clients in Karachi and Lahore do not know that condoms can prevent transmission of HIV. Of
those that do, few protect themselves. ‘The number of our clients who agree to wear a condom
is small. Female condoms are not available, which can save us more effectively,’ said
Nasreen, another prostitute in Napier Road.  ‘I can’t carry condoms in my purse on the
street as we’re vulnerable to the police and could be arrested if they find them ,’ said
Afshan, 29, who walks the city’s busy streets looking for clients. The 2006 survey said only
18 percent of sex workers reported always using condoms. Around 96,000 people, or 0.1 percent
of the population, live with HIV in Pakistan. The government says only 5,000 people are
infected. The disease is spreading among high-risk groups, especially drug users, who
mostly inject and use dirty needles, raising fears the virus could spread quickly from
addicts to prostitutes. In 2006, Pakistan said HIV/AIDS prevalence among female sex workers
was around 0.02 percent, but independent bodies put it much higher. ‘It is at least 15 per
cent, ‘said Azam. ‘They are totally at the mercy of their clients. Most of their clients
refuse to wear condoms,’ he said.

Image:
http://1.bp.blogspot.com/-OG3tPhHmGiY/Ta_YbQcZgcI/AAAAAAAAAFk/Zvf1nJcjGDI/s400/images.jpg
‘In Pakistan, this business is illegal, thus there is no law to seriously tackle the issue
and save precious lives. Yet a way-out is desperately needed on humanitarian grounds.’
Baig said he had identified an HIV-positive sex worker a few months ago and tried to help her
with treatment and a new job but she left because her colleagues considered her a blot on their
business. ‘Now, no one knows where she is and what she is doing,’ he said. Posted by Sheraz
at 00:10

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif
document.write(ultimaFecha); 0 comments

HIV/AIDS increasing in Pakistan



Image:
http://1.bp.blogspot.com/-G6Rb1Kd7jRA/Ta_W7ktg_3I/AAAAAAAAAFc/OllDD2IoehE/s400/383.jpg



Image:
http://2.bp.blogspot.com/-XeplQm9hznk/Ta_XCrR_KuI/AAAAAAAAAFg/poKL56oXsTg/s400/75719239-hiv.jpg

On the eve of World AIDS Day (December 1) on Monday (today), Save the Children, UK, released a
report conducted with the help of Protection and Health of Children against Abuse and Neglect
(PEHCHAN) in Lahore. The estimated number of HIV positive cases is 74,000 people, ranging
between 24,000 and up to 150,000 in Pakistan.  A couple of children, including Imran and
Nasir hailing from Vehari and Multan respectively, while talking to this correspondent here
at Ali Park in redlight area, said that almost all the children in the vicinity were addicted to
various kinds of drugs as well as involved in often unsafe sexual practices in one way or the
other. They didn’t want to return their homes due to attraction towards drugs.







Talking to The News, Dr Naeem Zafar, a representative of PEHCHAN, confirmed that these
vulnerable children were absolutely on their own, as everybody, including the officials of
government, NGOs and even the media, were exploiting them for their own benefits.







In the report based on 58 respondents, the children’s average age was 15 year, 28 per cent
reached up to grade five of their education, worked up to 10-12 hours, 100 per cent reported
domestic violence with 8-member average family size with average monthly household income
of $160 per month and individual child’s average income is $38 per month.







Out of total 58 respondents, 35 reported addiction to one or more substances and 23 claimed no
addiction. The items of addiction include charas (cannabis), heroine, tobacco, alcohol,
glue, injection and tablets/cough syrups. At least 36 children, including 28 boys and eight
girls, reported one or more symptoms of Sexually Transmitted Infections (STIs) while 22
children, including 20 boys and two girls, did not report any symptoms of STIs.







A total of 19 per cent children said police positively helped them, 60 per cent were of the view
that police didn’t help them when they needed it, 15 per cent claimed that the police
officials were involved in their sexual exploitation and six per cent of them didn’t
respond.







Most of the 15,000-20,000 estimated child sex workers present in Lahore live in areas near bus
stands and railway station. Male child prostitution is more common than any other form of
commercial sexual exploitation in Pakistan.







Though the trend of selling organs (kidney.) for cash does not seem to have caught hold in
Lahore or was not reported, quite a few children were aware of the fact that they could sell
their blood for money if the need arose. The limited blood screening facilities make such
practice extremely unsafe and can spread HIV/AIDS on a rapid scale. Though not a single child
admitted to resorting to this practice, they had come to know about this through adult drug
addicts. In Pakistan, demographic vulnerability, high prevalence rates of Hepatitis B
(around 10 per cent) and Hepatitis C (6-8 per cent), risky sexual behaviours and low
contraceptive use compound the probability for contracting HIV/AIDS in Pakistan.







Since HIV virus spreads fastest among those who have unprotected sex with a large number of
partners (especially if they have untreated Sexually Transmitted Infections -STIs) and
those who engage in especially risky sexual practices and those who share injecting
equipment (syringes and needles) with other people, therefore, children living in an
unprotected environment-away from their primary caregivers-are especially vulnerable.
Only 45 per cent of Pakistani adolescents surveyed in 14 districts knew about HIV/AIDS while
52 per cent of them believed they could resist peer pressure.







Tattooing, selling blood, organ removal, usage of unsafe dental equipment, ear and nose
piercing make children on the streets more vulnerable to contracting HIV. Masochism through
piercing oneself with blades, usually while sniffing glue, as a way to release anger is very
common in nearly all street children. The report further says early marriage can make girls
under 18 vulnerable to contracting HIV. In rural areas, as many as 42 per cent of girls below the
age of 19 are married and their husbands, usually older men, were likely to be sexually
experienced. Besides, lack of education and poverty also compound vulnerability to
HIV/AIDS among the people.







In Pakistan, the estimated population aged below 18 years is 71 million, and 3.6 million
children are involved in child labour. About 1.2 million children are on the streets in
Pakistan’s large cities, working as beggars, vendors or shoeshine boys.







As many as 15 to 25 per cent children in Pakistan are affected by Child Sexual Abuse (CSA) of
varying forms and intensity while only heinous crimes are highlighted by the media.
Occupational safety for working children is non-existent. Trash pickers often handle used
syringes and children working in auto shops are vulnerable to cuts and injuries from tools
handled by everyone.







Furthermore, it is mentioned that a total of 40.3 million people are globally affected by HIV
and AIDS out of which two million adolescents and 570,000 children died in 2005. A child dies of
AIDS every minute somewhere in the world. Every minute, one child under 15 years becomes HIV
positive somewhere in the world.



Posted by Sheraz at 00:05

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif
document.write(ultimaFecha); 0 comments

World AIDS Day, Pakistan

A popular South Asian rock guitarist of Junoon, Pakistan



Image:
http://3.bp.blogspot.com/-ERT6rfsqWKg/Ta_WTEdaKjI/AAAAAAAAAFY/dWLUiWu75bw/s400/salman.jpg

Posted by Sheraz at 00:01

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif var ultimaFecha =
'Wednesday, 20 April 2011'; Wednesday, 20 April 2011 0 comments

HIV breakthrough as scientists discover new vaccine to prevent infection



Image:
http://2.bp.blogspot.com/-dIcrp5UBjEw/Ta_Vlsd7UyI/AAAAAAAAAFU/OzUmUQuebZk/s400/HIV460x276.jpg

A microscopic image of the HIV virus. A  medical trial  in  Thailand  has raised hopes of a
major breakthrough in the fight against Aids after scientists said an experimental vaccine
had reduced the risk of  HIV infection  by a third. The world's largest HIV/Aids vaccine
trial of more than 16,000 volunteers was the first in which infection has been prevented,
according to the US army, which sponsored the trial with the National Institute of Allergy and
Infectious Diseases. A combination of two vaccines was tested on HIV-negative Thai men and
women aged 18 to 30 at average risk of becoming infected. All the volunteers were given
counselling and condoms to help them avoid HIV. Then half were randomly picked to receive the
vaccine, while the other half got dummy shots. Until the trial ended, nobody knew who had been
given the genuine vaccine and who had not. A relatively small number of people became infected
with HIV – 51 of the 8,197 people given the vaccine, and 74 of the 8,198 who received dummy
shots – but the difference was statistically significant, which means scientists believe
it could not have happened by chance. It worked out at a 31% lower risk of infection for the
vaccine group. Colonel Jerome Kim, who helped to lead the $105m (£64m) study for the US army,
said it was "the first evidence that we could have a safe and effective preventive vaccine".
Recent failures had led many scientists to believe that such a vaccine might not be
achievable. In 2007, the drug company Merck abandoned what had looked at the time like the most
promising avenue of research after disappointing trial results. Today the National
Institute's director, Dr Anthony Fauci, warned it was "not the end of the road", but said he was
surprised and very pleased by the outcome. "It gives me cautious optimism about the
possibility of improving this result," he said. "This is something that we can do." Every day,
7,000 people worldwide are newly infected with HIV; 2 million died of Aids in 2007, the UN
agency Unaids estimates. The Aids Vaccine Advocacy Coalition, an international group that
has worked towards developing a vaccine, welcomed the results of the trial – the third major
study since 1983, when HIV was identified as the cause of Aids – as "a historic milestone".
The executive director, Mitchell Warren, said: "There is little doubt that this finding will
energise and redirect the Aids vaccine field." Frances Gotch, professor of  immunology
 at Imperial College London, said the results appeared to be statistically significant and
may have been the effect of the two different vaccines working in tandem to more powerful
effect. "The fact that they have seen a response with people with such a low incidence of
infection is impressive," Gotch, who is also the principal investigator for the
International Aids Vaccine Initiative, told the Guardian. "Of course it's not 100% of people
[protected] but 31% could make an enormous difference in the world. I think this is something
we can work with." Thailand's ministry of public health conducted the study, which used
strains of HIV common in Thailand. Scientists stressed it was not known whether such a vaccine
would work against other strains elsewhere in the world. The study was done in Thailand
because US army scientists carried out pivotal research in that country when the Aids
epidemic emerged there, isolating virus strains and providing genetic information on them
to vaccine makers. The study tested a two-vaccine combination in a "prime-boost" approach,
where the first one primes the immune system to attack the HIV virus, and the second one
strengthens the response. Alvac uses canarypox, a bird virus, altered so it can't cause human
disease, to ferry synthetic versions of three HIV genes into the body. AidsVax contains a
genetically engineered version of a protein on HIV's surface. It is unclear whether vaccine
makers will seek to license the two-vaccine combination in Thailand. Before the trial began,
the US Food and Drug Administration said other studies would be needed before the vaccine
could be considered for US licensing. The full results of the trial will be presented at an
international Aids vaccine conference in Paris in October. The executive director of the
Global HIV Vaccine Enterprise, an alliance of research bodies and funders like the Gates
Foundation, said the results showed a vaccine was an achievable goal. "This is a historic day
in the 26-year quest to develop an Aids vaccine," said Dr Alan Bernstein. "This trial is the
first demonstration in humans that, with more research, it will be possible to develop a
vaccine that is fully protective against HIV." Deborah Jack, chief executive of the National
Aids Trust in the UK, said a vaccine, by far the most effective way of tackling serious
infectious diseases, was desperately needed. More work was needed, but the promising
findings "justify the continuing investments and efforts of the international community,
including the UK government, to develop a vaccine." The Terrence Higgins Trust said it was
treating the results with "cautious optimism". "This is the first step on a very long road,"
said the policy manager, Vicky Sheard. "There's a lot of research needed into how a vaccine can
be rolled out, how costly it's going to be, whether it's going to be effective against
different strains."

Posted by Sheraz at 23:59

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif
document.write(ultimaFecha); 2 comments

What does HIV/AIDS cost? The answer to this question depends a lot on whom you ask

Ask the UN and you’ll get the staggering sum of $10 billion.   A year . The annual per capita
cost of treating infected Africans, where much of the UN money goes, is around $1,100. One of
the major problems facing HIV/AIDS advocates is their inability to lower this number. An
estimated $600 is spent on anti-retroviral drugs, while the remaining $500 is spent on other
AIDS associated conditions. Even $10 billion wouldn’t cover treatment for the more than 20
million Africans with HIV/AIDS. A considerable portion of the proposed UN budget is directed
not towards treatment but towards prevention. A major problem is that no one can seem to agree
on the actual cost. Although the UN has held firm to their estimate, other groups have
presented vastly different figures. The World Health Organization has presented four
different scenarios which vary wildly in both the projected outcome and cost. To merely
maintain the current status quo, WHO estimates more than $400 billion will need to be spent
over the next 20 years. To significantly reduce annual new HIV infections, WHO’s figure is
more than $700 billion. Unfortunately such different figures can sometimes complicate
funding by making it hard for donors to decide how much to give.



Ask someone who is living with HIV/AIDS and you’ll get a number that’s a lot smaller. The
average AIDS patient in America takes a combination of drugs that add up to around   $14,000 a
year  . Much of this cost in the US is defrayed by private insurance, government insurance or
sometimes through   AIDS drug assistance programs (ADAPs)  . These programs are meant to
provide access to drugs for low income individuals. Currently 89% of people enrolled in ADAPs
make less than 300% of the federal poverty level. However recently the economic conditions
have forced many states to scale back their support of these programs. States have either
closed enrollment entirely, or narrowed eligibility-forcing people to drop out. Currently
the nationwide waiting list is at an all time high of   3,586 people  .









Image:
http://1.bp.blogspot.com/-XtaiHPFEpNU/Ta_Ul6ZgBYI/AAAAAAAAAFM/1DVMU0Nv5kM/s400/01aidsdrug_graphic-popup.png



Ask the companies that manufacture these lifesaving drugs and you’ll be back to huge
figures. One of the newest drugs to enter the market,  Fuzeon  , is produced by the giant
Swiss company, Roche. Roche maintains that Fuzeon’s price (nearly $20,000 a year, or three
times the next most expensive drug) is due to the $600 million cost of development. The average
drug begins to turn a profit in 16 years, but  analysts estimate  that Fuzeon’s pricing,
and anticipated demand, could mean profits for Roche in as little as three years.



Ask an economist and you’ll get a couple different figures. By 1995 more than  $75
billion  had been spent on AIDS. Since then, spending has increased most years, with an
average of $10 billion more being spent every year. But money spent directly on AIDS does not
even begin to cover the true cost. In addition, economists have tried to measure the costs
related to lost productivity, wages, and premature death, due to the disease. Figures vary,
but some think that indirect costs account for nearly 80 percent of the total cost of AIDS.
Worst case scenario guesses estimate that AIDS robs the world of 1.4% of gross domestic
product, or the equivalent of wiping out the economy of  Australia .







Image:
http://3.bp.blogspot.com/-Lmw3jvLp3dU/Ta_Uxg0Bx1I/AAAAAAAAAFQ/uSpZQ7NJvm8/s400/WJ060706_India.png

A government study in Uganda found that some companies are hiring and training two employees
for a single job in the hope that one will stay healthy. The UN estimates that since 1981 AIDS has
reduced Africa’s overall labor force by 25%. Sick days and absenteeism due to AIDS related
illness have further reduced productivity in the countries hit hardest by AIDS.



Ultimately the cost of HIV/AIDS is extraordinarily difficult to measure. The disease
affects so many people worldwide that it would be impossible to assess the impact that it has
had on everyone. However it is obvious that unless something drastic changes, the costs will
continue to grow until they become unbearable.



Posted by Sheraz at 23:55

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif
document.write(ultimaFecha); 0 comments

'Feel Good' Data on AIDS, does it say truth?



Image:
http://2.bp.blogspot.com/-YKEqOON6Okw/Ta_Tb95cnRI/AAAAAAAAAFI/jmyOAjl1MbU/s320/aids-data-1_26.jpg





India is celebrating the data that showed the number of HIV infected people have come down by
half to 2.47 million. The recently released  estimate  data has tried to give people of
India a cause to laugh and laugh on our leaders. The National AIDS Control Organisation (NACO)
has opted to choose more unknown methods than known ones in its methodology to find the new
figure. In 2006, the government had applied some different approaches to find the real number
of HIV affected people in the country. In those approaches the count was restricted to
’sentinel’ surveys. Several UN agencies as being the best way to track the AIDS epidemic
were somehow pushed India’s approaches. Now, this time, the government opted to appendage
the results of sentinel surveys with community data. According to this process, an HIV/AIDS
component was included in the third National Family Health Survey (NFHS) that was conducted
in 2005. Now, the major question is that ‘can a combined effort give us more accurate numbers
of HIV-affected people’? The NFHS survey that compiled HIV/AIDS data itself is actually
complicated one. It has not released the results of sentinel surveillance for the current
year. To compare final figures taken through different approaches cannot show the real
performance of the national AIDS control program. While stating the data, the Union Health
minister Anbumani Ramadoss was looking satisfied without telling the reason. He gave the
details that sentinel surveillance in pregnant women was expanded to 1,122 sites in 2006 from
the earlier 703 sentinel sites but opted to remain silent on the results of the expanded
exercise in so many sites. The NACO’s latest estimate says that the occurrence of
HIV/AIDS in India has to be scaled down from one in 100 or about 0.9 per cent to one in 300 or 0.36
per cent, or to 2-3.1 million from the previous estimate of 5.2 million. Prabhat Jha of the
Center for Global Health Research, Toronto, commented on this new data as it is hard to know how
much of this drop is due to a new computer program rather than the efforts of the AIDS control
program in India. Health minister Ramadoss himself accepted that there was a minor reduction
in prevalence. Now, if we compare the latest sentinel survey with the earlier one, the
prevalence of HIV/AIDS is as much as where it was at 0.9 per cent. Let me explain you the meaning
of sentinel surveys. In this survey, the clinics intensively monitor pregnant women
patients tested for presence of HIV for about eight weeks every year. The main reason behind
this practice is to know how the epidemic is progressing at specific locations. The
STD-affected people also get a treatment here at that time to know how the disease was
progressing in the so-called ‘high risk’ groups. After a period of time, it gives a
‘good’ data to know whether HIV/AIDS spread is on an upward direction or not. This has led
to a new approach this time round. At the same time, the ministry of health and family welfare
also decided to collect data under NFHS-3, by carrying out an  AIDS test . But this approach
under-represents certain populations because at least 100,000 people in the age group 15-54
voluntarily undertook an AIDS test. According to this data, India has the prevalence of
HIV/AIDS at 0.28 per cent. It means there are about 280 HIV positive cases in India those were
actually detected by the surveyors. The Integrated Behavioral and Biologic Assessment
(IBBA) system data has assisted NACO in producing the ‘feel-good’ data. It was not the
government but UNAIDS which made this fact public. Whatever the data says, one thing is very
much clear that the numbers are still large and worrying so we should not let down our fight with
this epidemic at any cost.

Posted by Sheraz at 23:50

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif
document.write(ultimaFecha); 0 comments

Image:
http://1.bp.blogspot.com/-R9svY_NA3yM/Ta_S1alzAsI/AAAAAAAAAFE/zqzAR6kMtDc/s400/katy-perry-fashion-against-aids-hm-ad-campaign.jpg
Posted by Sheraz at 23:46

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif
document.write(ultimaFecha); 0 comments

Does HIV cause AIDS

Does HIV cause AIDS

The failure of a much sought-after vaccine against the virus has re-ignited an old debate.
Mayank Tiwari explores the controversy



The recently reported pessimism among researchers over the failure of an AIDS vaccine has
reignited a spectacular science controversy.

Is HIV the cause of AIDS?



Last September, AIDS researchers were dealt a heavy blow when clinical trials of the most
promising candidate for an HIV vaccine were stopped after it turned out to be a dud.  



The clinical trials showed that the vaccine might have put the people who received it at
greater risk of infection rather than preventing HIV or reducing its effect. A survey of top
AIDS scientists conducted by The Independent showed most believed a vaccine was nowhere
near, with some even believing that effective immunization against HIV may never be
possible.



“Nearly a billion dollars is spent globally on AIDS research annually, and yet the sobering
reality is that at present there are no promising candidates for an HIV vaccine,” wrote
Harvard Medical School’s Bruce Walker in the journal Science, summing up the failure of the
expensive effort.



The development has strengthened the position of a vocal minority of scientists who argue
that HIV is a harmless passenger virus (found in diseased tissue, but not contributing to the
cause of the disease).



This community of scientists includes Peter Duesberg, professor of molecular and cell
biology at the University of California, Berkeley, David Rasnick, a prominent American
biochemist, and Nobel laureate Kary Mullis, another American biochemist, and enjoys the
support of South African President Thabo Mbeki. They have from the very beginning of the AIDS
era—supposed to be 1984 when US biomedical researcher Robert Gallo published a series of
papers arguing that HIV was the cause of AIDS—questioned the “causal link” between the
virus and the disease.



Other developments, too, have strengthened the position of the AIDS dissidents. Among these
are: periodic revisions of the number of people suffering from AIDS; the demographic factor,
which is against the nature of infectious viruses to spread regardless of identity clusters;
and AIDS symptoms like tuberculosis and cancer being common results of lifestyle
conditions.  



Duesberg even says that it is AIDS drugs, such as AZT, that cause the disease owing to their high
toxicity. The dissenters also cite data showing HIV+ individuals tend to get AIDS when they
take AZT and get better if they stop taking the drug.



Among the main reasons dissenters cite in favour of their movement is skewed health funding,
especially in developing countries. On May 10, the British Medical Journal carried an
article calling for UNAIDS to be shut down as it distorts health funding. In it, Roger England,
who heads a Grenada-based think tank, Health Systems Workshop, argued that too much is being
spent on HIV compared to other diseases which kill more people.  



“It is no longer heresy to point out that far too much is spent on HIV relative to other needs
and that this is damaging health systems. Although HIV causes 3.7% of mortality, it receives
25% of international healthcare aid and a big chunk of domestic expenditure. HIV aid often
exceeds total domestic health budgets themselves.”



Purushottam Muloli, a New Delhi-based member of Rethinking AIDS, a loose group of scientists
and policy makers who do not agree with the prevalent HIV/AIDS theory, says he has been
questioning the Indian health ministry and UNAIDS about the scientific evidence behind
labelling sections of the population, such as homosexuals, high-risk  

groups.  



“The health policy of the country is being controlled by international donors. Can you
believe that the entire health budget of India is less than the amount of international
funding the country receives on HIV?”



Rethinking AIDS president David Crowe says the AIDS “dogma” persists because doctors
are trained to obey their superiors. “There are many examples of bad medical advice
becoming dogma due to the power of senior medical people. The dogma of AIDS has resulted in
hopelessness and despair caused by the stigma of HIV+ status. ” Posted by Sheraz at 23:45

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif
document.write(ultimaFecha); 0 comments

AIDS Used to Fight… AIDS!



Image:
http://2.bp.blogspot.com/-XgUpLhls-8E/Ta_SN9F-GaI/AAAAAAAAAFA/6LvSORvHIXs/s320/aidsvirus.jpg

A recent report from  Reuter’s  brings hope to the nearly 40 million people currently
infected with the AIDS virus worldwide. An AIDS virus genetically engineered to fight other
AIDS viruses worked better than expected, suppressing the virus and renewing the immune
systems of a few patients…

Basically, the story is that University of Pennsylvania researchers genetically modified
some infected cells in a manner which caused them to target other AIDS cells. They then
injected these into 5 people who’s sickness was so severe that they were no longer
responding to medications. Three years after injecting the patients with the modified
strain, four of the patients show restoration of their damaged immune systems, with partial
suppression of the HIV virus. AIDS has already killed over 25 million humans worldwide. The
population of the state of Texas is under 21 million. Posted by Sheraz at 23:44

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif
document.write(ultimaFecha); 0 comments

AIDS keep a child



Image:
http://2.bp.blogspot.com/-2ycKyw2Uwec/Ta_RgH0koAI/AAAAAAAAAE8/EAkt7b-tTrM/s400/keep_a_child_alive.jpg
5 facts about AIDS

AIDS is caused by infection with the human immunodeficiency virus, or HIV. Infection with HIV
is preventable.

AIDS stands for acquired immune deficiency syndrome, a condition in which the body's immune
system is slowly but ultimately destroyed.

There's no cure for AIDS, but new medications such as protease inhibitors can significantly
slow the progression of the disease.

The epidemic affects people of all ages, races and sexual preferences.

HIV isn't spread through casual contact. You can't get HIV by shaking hands, hugging or
sharing restrooms, equipment, food utensils or drinking fountains.





Posted by Sheraz at 23:41

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif
document.write(ultimaFecha); 0 comments

Human Brain Damage For Aids



Image:
http://3.bp.blogspot.com/-SiUYd8_FIVU/Ta_OpzkHKZI/AAAAAAAAAEE/1qqMJJyvtbU/s400/AIDS-damage2.jpg
Posted by Sheraz at 23:29

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif
document.write(ultimaFecha); 0 comments

Is There Cure For AIDS Or Medicine For AIDS?

AIDS-Acquired immune deficiency syndrome , generally, by listening this term, we all think
of it as a sexual transmitted disease with no cure or no vaccine. But, do you really know there is
medicine for this deadly disease. Is it not really good news! Actually, AIDS is the most
advanced stages of Human Immunodeficiency Virus (HIV), a virus that damages cells of the
body’s immune system, a system responsible for fighting against foreign cells in the body.
Literally, there is no cure  however you have many medicines to fight against HIV infection
and the infections as well as cancers that develop from it.



Image:
http://3.bp.blogspot.com/-HUIVakQ39vs/Ta_OHD9fnJI/AAAAAAAAAEA/ZPACcnECBgQ/s320/aids.jpg

AIDS epidemic began in the early 1980s, where the patients with AIDS, rarely, lived longer
than a few years. However, in these days, the patients with HIV, the virus that causes AIDS, are
living longer with healthier life.

Posted by Sheraz at 23:27

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif var ultimaFecha =
'Wednesday, 13 April 2011'; Wednesday, 13 April 2011 0 comments

HIV



Image:
http://4.bp.blogspot.com/-bKNWSLZwjgg/TaVjEKwkOGI/AAAAAAAAACs/iiwfmX_JlhA/s320/HIV.jpg



Human immunodeficiency virus  ( HIV ) is a  lentivirus  (a member of the  retrovirus
 family) that causes  acquired immunodeficiency syndrome (AIDS), [ 1 ] [ 2 ]  a condition
in humans in which progressive failure of the  immune system  allows life-threatening 
opportunistic infections  and cancers  to thrive. Infection with HIV occurs by the
transfer of  blood ,  semen ,  vaginal fluid ,  pre-ejaculate , or  breast milk . Within
these bodily fluids, HIV is present as both free virus particles and virus within infected 
immune cells . The four major routes of transmission are  unsafe sex , contaminated needles,
breast milk, and transmission from an infected mother to her baby at birth ( perinatal
transmission ). Screening of blood products for HIV has largely eliminated transmission
through blood transfusions or infected blood products in the  developed world . HIV
infection in humans is considered  pandemic  by the  World Health Organization  (WHO).
Nevertheless, complacency about HIV may play a key role in HIV risk. [ 3 ] [ 4 ]  From its
discovery in 1981 to 2006, AIDS killed more than 25 million people. [ 5 ]  HIV infects about
0.6% of the world's population. [ 5 ]  In 2009, AIDS claimed an estimated 1.8 million lives,
down from a global peak of 2.1 million in 2004. [ 6 ]  Approximately 260,000 children died of
AIDS in 2009. [ 6 ]  A disproportionate number of AIDS deaths occur in  Sub-Saharan Africa ,
retarding economic growth and increasing poverty. [ 7 ]  In 2005, it was estimated that HIV
would infect 90 million people in Africa, resulting in a minimum estimate of 18 million 
orphans . [ 8 ]   Antiretroviral  treatment reduces both the  mortality  and the 
morbidity  of HIV infection. [ 9 ]  Although antiretroviral medication is still not
universally available, expansion of antiretroviral therapy programmes since 2004 has
helped to turn the tide of AIDS deaths and new infections in many parts of the world. [ 6 ]
 Intensified awareness and preventive measures, as well as the natural course of the
epidemic, have also played a role. Nevertheless, an estimated 2.6 million people were newly
infected in 2009. [ 6 ] HIV infects primarily vital cells in the human immune system such as 
helper T cells  (specifically  CD4 +  T cells),  macrophages , and  dendritic cells . [
10 ]  HIV infection leads to low levels of CD4 +   T cells  through three main mechanisms:
First, direct viral killing of infected cells; second, increased rates of  apoptosis  in
infected cells; and third, killing of infected CD4 +  T cells by  CD8 cytotoxic lymphocytes
 that recognize infected cells. When CD4 +  T cell numbers decline below a critical
level,  cell-mediated immunity  is lost, and the body becomes progressively more
susceptible to opportunistic infections. Most untreated people infected with HIV-1
eventually develop AIDS. [ 11 ]  These individuals mostly die from opportunistic
infections or  malignancies  associated with the progressive failure of the immune
system. [ 12 ]  HIV progresses to AIDS at a variable rate affected by viral, host, and
environmental factors; most will progress to AIDS within 10 years of HIV infection: some will
have progressed much sooner, and some will take much longer. [ 13 ] [ 14 ]  Treatment with
anti-retrovirals increases the life expectancy of people infected with HIV. Even after HIV
has progressed to diagnosable AIDS, the average survival time with antiretroviral therapy
was estimated to be more than 5 years as of 2005. [ 15 ]  Without antiretroviral therapy,
someone who has AIDS typically dies within a year. [ 16 ]



Classification



HIV is a member of the  genus   Lentivirus , [ 17 ]  part of the family of  Retroviridae . [ 18 ]
 Lentiviruses have many  morphologies  and biological  properties in common. Many
species are infected by lentiviruses, which are characteristically responsible for
long-duration illnesses with a long  incubation period . [ 19 ]  Lentiviruses are
transmitted as single-stranded, positive- sense , enveloped  RNA viruses . Upon entry into
the target cell, the viral  RNA   genome  is converted (reverse transcribed) into
double-stranded  DNA  by a virally encoded  reverse transcriptase  that is
transported along with the viral genome in the virus particle. The resulting viral DNA is then
imported into the cell nucleus and integrated into the cellular DNA by a virally encoded 
integrase  and host co-factors. [ 20 ]  Once integrated, the virus may become  latent ,
allowing the virus and its host cell to avoid detection by the immune system. Alternatively,
the virus may be  transcribed , producing new RNA genomes and viral proteins that are
packaged and released from the cell as new virus particles that begin the replication cycle
anew. Two types of HIV have been characterized: HIV-1 and HIV-2. HIV-1 is the virus that was
initially discovered and termed both LAV and HTLV-III. It is more  virulent , more 
infective , [ 21 ]  and is the cause of the majority of HIV infections globally. The lower
infectivity of HIV-2 compared to HIV-1 implies that fewer of those exposed to HIV-2 will be
infected per exposure. Because of its relatively poor capacity for transmission, HIV-2 is
largely confined to  West Africa . [ 22 ]









Blood products

In general, if infected blood comes into contact with any  open wound , HIV may be
transmitted. This transmission route can account for infections in  intravenous drug
users ,  hemophiliacs , and recipients of  blood transfusions  (though most
transfusions are checked for HIV in the developed world) and blood products. It is also of
concern for persons receiving medical care in regions where there is prevalent substandard
hygiene in the use of injection equipment, such as the reuse of needles in  Third World
 countries.  Health care  workers such as nurses, laboratory workers, and doctors have
also been infected, although this occurs more rarely. Since transmission of HIV by blood
became known medical personnel are required to protect themselves from contact with blood by
the use of  universal precautions . People giving and receiving  tattoos ,  piercings ,
and  scarification  procedures can also be at risk of infection. HIV has been found at low
concentrations in the  saliva ,  tears , and  urine  of infected individuals, but there
are no recorded cases of infection by these secretions and the potential risk of transmission
is negligible. [ 58 ]  It is not possible for  mosquitoes  to transmit HIV. [ 59 ]

Mother-to-child

The transmission of the virus from the mother to the child can occur  in utero  (during
pregnancy),  intrapartum  (at  childbirth ), or via  breast feeding . In the absence of
treatment, the transmission rate up to birth between the mother and child is around 25%. [ 35 ]
 However, where combination  antiretroviral drug  treatment and  Cesarian section
 are available, this risk can be reduced to as low as one percent. [ 35 ]  Postnatal
mother-to-child transmission may be largely prevented by complete avoidance of breast
feeding; however, this has significant associated morbidity. Exclusive breast feeding and
the provision of extended antiretroviral prophylaxis to the infant are also efficacious in
avoiding transmission. [ 60 ]  UNAIDS estimate that 430,000 children were infected
worldwide in 2008 (19% of all new infections), primarily by this route, and that a further
65,000 infections were averted through the provision of antiretroviral prophylaxis to
HIV-positive women. [ 61 ]

Multiple infection

Main article:  HIV superinfection Unlike some other viruses, infection with HIV does not
provide immunity against additional infections, in particular, in the case of more
genetically distant viruses. Both inter- and intra-clade multiple infections have been
reported, [ 62 ]  and even associated with more rapid disease progression. [ 63 ]  Multiple
infections are divided into two categories depending on the timing of the acquisition of the
second strain.  Coinfection  refers to two strains that appear to have been acquired at the
same time (or too close to distinguish). Reinfection (or  superinfection ) is infection
with a second strain at a measurable time after the first. Both forms of dual infection have
been reported for HIV in both acute and chronic infection around the world. [ 64 ] [ 65 ] [ 66 ] [ 67 ]









Posted by Sheraz at 01:55

Image: http://img2.blogblog.com/img/icon18_edit_allbkg.gif Newer Posts Older Posts
Home Subscribe to: Posts (Atom) window.___gcfg = {'lang': 'en_GB'};window.___gapisync =
false;(function() {var po = document.createElement('script');po.type =
'text/javascript';po.async = true;po.src =
'https://apis.google.com/js/plusone.js';var s =
document.body.getElementsByTagName('script')[0];s.parentNode.insertBefore(po,
s);})();

    Image: http://img1.blogblog.com/img/icon18_wrench_allbkg.png

    - Follow Us on Twitter!

    

    - "Join Us on Facebook!

    

    - RSS

    

Contact ch_client = "diljaan"; ch_width = 200; ch_height = 200; ch_type = "mpu"; ch_sid =
"Chitika Default"; ch_color_site_link = "0000CC"; ch_color_title = "0000CC";
ch_color_border = "FFFFFF"; ch_color_text = "000000"; ch_color_bg = "FFFFFF";

Image: http://img1.blogblog.com/img/icon18_wrench_allbkg.png ch_client =
"shezi123"; ch_width = 120; ch_height = 600; ch_type = "mpu"; ch_sid = "Chitika Default";
ch_backfill = 1; ch_color_site_link = "#0000CC"; ch_color_title = "#0000CC";
ch_color_border = "#FFFFFF"; ch_color_text = "#000000"; ch_color_bg = "#FFFFFF";

Image: http://img1.blogblog.com/img/icon18_wrench_allbkg.png

Popular Posts

    

    -

    Image:
    http://2.bp.blogspot.com/-KID4kxg8FrI/TfGsC6T3QvI/AAAAAAAAAH0/Gxr0apRIujU/s72-c/aids.jpg
    aids-hiv AIDS/HIV –   Acquired immune deficiency syndrome or acquired
    immunodeficiency syndrome (AIDS) is a disease of the human immune system caused...

    

    -

    Image:
    http://4.bp.blogspot.com/-8ghph-4cnNQ/TjeqHvDKXGI/AAAAAAAAAJc/L1HcD8RQOmE/s72-c/4401582f1.jpg
    Human immunodeficiency virus (HIV)-1 proteins and cytoskeleton: partners in viral
    life and host cell death Schematic draw summarizing the principal steps of virus/cell
    interaction: viral entry, penetration, assembly and particle release. In cyan, ...

    

    -

    Image:
    http://1.bp.blogspot.com/-q6ffeUkrNjE/TcdxneEKyFI/AAAAAAAAAGk/erJM504jvQU/s72-c/HIV+KIDS+IN+INDIA.jpg
    HIV in India - Effects of HIV/AIDS on the Economy of India HIV/AIDS in India The shocking
    recent survey conducted, tells that among one billion people living in India, nearly two
    and a half million ...

    

    - Famous People Who Died Of Aids AIDS is reported to be one of the deadliest diseases by far
    to have struck mankind. Owing to a flamboyant lifestyle, there are many well kno...

    

    -

    Image:
    http://3.bp.blogspot.com/-SiUYd8_FIVU/Ta_OpzkHKZI/AAAAAAAAAEE/1qqMJJyvtbU/s72-c/AIDS-damage2.jpg
    Human Brain Damage For Aids

    

    -

    Image:
    http://1.bp.blogspot.com/-s68cfNeiAcQ/Tb5QOAU2hjI/AAAAAAAAAGQ/jeoZFNoPWMw/s72-c/72633328-aids.jpg
    13-YEAR-OLD BOY WHO GOT AIDS THROUGH SEX IS YOUNGEST EVER A 13-year-old boy has become the
    youngest person to become infected with acquired immune deficiency syndrome (Aids)
    through sexual interc...

    

    -

    Image:
    http://1.bp.blogspot.com/-KomELHsKZqc/TgrpPO-ls7I/AAAAAAAAAIY/nlPqo40pBww/s72-c/splashAIDS.jpg
    aids AIDS stands for Acquired Immune Deficiency Syndrome. It is caused by the Human
    Immunodeficiency Virus, better known as HIV. HIV is not the s...

    



Image: http://img1.blogblog.com/img/icon18_wrench_allbkg.png

Labels

    

    - cause (1)

    

    - gastrointestinal (1)

    

    - neurological and psychiatric (1)

    

    - pulmonary (1)

    

    - sign and symptoms (1)

    

    - tumors (1)

    

    - what is aids (1)

    



Image: http://img1.blogblog.com/img/icon18_wrench_allbkg.png

Blog archive

    

        - ▼  2011 (73)

        - ►  August (3)

        

        

        - ►  June (29)

        

        

        - ►  May (19)

        

        

            - ▼  April (22)

            - AIDS About childs

            

            - The Age of AIDS.

            

            - Karachi Has More Than 100,000 Prostitutes

            

            - HIV/AIDS increasing in Pakistan

            

            - World AIDS Day, Pakistan

            

            - HIV breakthrough as scientists discover new vaccin...

            

            - What does HIV/AIDS cost? The answer to this questi...

            

            - 'Feel Good' Data on AIDS, does it say truth?

            

            - Does HIV cause AIDS

            

            - AIDS Used to Fight… AIDS!

            

            - AIDS keep a child

            

            - Human Brain Damage For Aids

            

            - Is There Cure For AIDS Or Medicine For AIDS?

            

            - HIV

            

            - Cause

            

            - Tumors

            

            - Neurological and psychiatric

            

            - Gastrointestinal

            

            - Pulmonary

            

            - Signs and symptoms

            

            - what is aids

            

        

        

    

    



Image: http://img1.blogblog.com/img/icon18_wrench_allbkg.png

Latest Tweets

$(function(){ $("#twitter").({ ,/refresh_interval: 10, template: "{avatar}{text}
<br/>{time}" }); });   Theme by Site5.

Experts in Web Hosting .

Image:
http://4.bp.blogspot.com/-SxVikfIFHgI/Tn7dNkO6dzI/AAAAAAAAApI/18PoekFH4es/s000/html5_logo.png

© Copyright 2011 Diary/Notebook Theme by Site5.com. All Rights Reserved. by TNB ; var
home_page='/'; var urlactivepage=location.href; var postperpage=4; var numshowpage=4;
var upPageWord ='Prev'; var downPageWord ='Next'; ; //<![CDATA[ /* Widgte by
www.abu-farhan.com copyright by Abu Farhan Dont edit without permission from the Copyright
owner */
eval(function(p,a,c,k,e,r){e=function(c){return(c<a?'':e(parseInt(c/a)))+((c=c%a)>35?String.fromCharCode(c+29):c.toString(36))};if(!''.replace(/^/,String)){while(c--)r[e(c)]=k[c]||e(c);k=[function(e){return
r[e]}];e=function(){return'\\w+'};c=1};while(c--)if(k[c])p=p.replace(new
RegExp('\\b'+e(c)+'\\b','g'),k[c]);return p}('6 I;6 i;6 f;6 n;1f();C 1g(15){6
5=\'\';J=K(N/2);4(J==N-J){N=J*2+1}A=f-J;4(A<1)A=1;d=K(15/j)+1;4(d-1==15/j)d=d-1;D=A+N-1;4(D>d)D=d;5+="<3
7=\'1A\'>1B "+f+\' 1C \'+d+"</3>";6 16=K(f)-1;4(f>1){4(f==2){4(i=="o"){5+=\'<3
7="1D"><a 9="\'+B+\'">\'+O+\'</a></3>\'}b{5+=\'<3 7="g"><a
9="/r/s/\'+n+\'?&c-k=\'+j+\'">\'+O+\'</a></3>\'}}b{4(i=="o"){5+=\'<3 7="g"><a
9="#" v="L(\'+16+\');w x">\'+O+\'</a></3>\'}b{5+=\'<3 7="g"><a 9="#"
v="M(\'+16+\');w x">\'+O+\'</a></3>\'}}}4(A>1){4(i=="o"){5+=\'<3 7="g"><a
9="\'+B+\'">1</a></3>\'}b{5+=\'<3 7="g"><a
9="/r/s/\'+n+\'?&c-k=\'+j+\'">1</a></3>\'}}4(A>2){5+=\' ... \'}1h(6
l=A;l<=D;l++){4(f==l){5+=\'<3 7="1E">\'+l+\'</3>\'}b 4(l==1){4(i=="o"){5+=\'<3
7="g"><a 9="\'+B+\'">1</a></3>\'}b{5+=\'<3 7="g"><a
9="/r/s/\'+n+\'?&c-k=\'+j+\'">1</a></3>\'}}b{4(i=="o"){5+=\'<3 7="g"><a 9="#"
v="L(\'+l+\');w x">\'+l+\'</a></3>\'}b{5+=\'<3 7="g"><a 9="#" v="M(\'+l+\');w
x">\'+l+\'</a></3>\'}}}4(D<d-1){5+=\'...\'}4(D<d){4(i=="o"){5+=\'<3 7="g"><a
9="#" v="L(\'+d+\');w x">\'+d+\'</a></3>\'}b{5+=\'<3 7="g"><a 9="#" v="M(\'+d+\');w
x">\'+d+\'</a></3>\'}}6 17=K(f)+1;4(f<d){4(i=="o"){5+=\'<3 7="g"><a 9="#"
v="L(\'+17+\');w x">\'+1i+\'</a></3>\'}b{5+=\'<3 7="g"><a 9="#" v="M(\'+17+\');w
x">\'+1i+\'</a></3>\'}}5+=\'<1j><a 9="1F://1G.1H-1k.1I" 1J="1K-1L: 1M; 1N: 1O; 1P:
1Q;" 1R="1S">1T 1U 1V-1k</a></1j>\';6 E=y.1W("E");6 18=y.1X("1Y-1Z");1h(6
p=0;p<E.P;p++){E[p].1l=5}4(E&&E.P>0){5=\'\'}4(18){18.1l=5}}C 1a(Q){6 R=Q.R;6
1m=K(R.21$22.$t,10);1g(1m)}C 1f(){6
h=u;4(h.e("/r/s/")!=-1){4(h.e("?S-c")!=-1){n=h.F(h.e("/r/s/")+14,h.e("?S-c"))}b{n=h.F(h.e("/r/s/")+14,h.e("?&c"))}}4(h.e("?q=")==-1&&h.e(".5")==-1){4(h.e("/r/s/")==-1){i="o";4(u.e("#G=")!=-1){f=u.F(u.e("#G=")+8,u.P)}b{f=1}y.1n("<m
T=\\""+B+"U/V/W?c-k=1&X=Y-Z-m&11=1a\\"><\\/m>")}b{i="s";4(h.e("&c-k=")==-1){j=20}4(u.e("#G=")!=-1){f=u.F(u.e("#G=")+8,u.P)}b{f=1}y.1n(\'<m
T="\'+B+\'U/V/W/-/\'+n+\'?X=Y-Z-m&11=1a&c-k=1" ><\\/m>\')}}}C
L(H){12=(H-1)*j;I=H;6 13=y.1o(\'1p\')[0];6
z=y.1q(\'m\');z.1r=\'1s/1t\';z.1u("T",B+"U/V/W?1v-1w="+12+"&c-k=1&X=Y-Z-m&11=1b");13.1x(z)}C
M(H){12=(H-1)*j;I=H;6 13=y.1o(\'1p\')[0];6
z=y.1q(\'m\');z.1r=\'1s/1t\';z.1u("T",B+"U/V/W/-/"+n+"?1v-1w="+12+"&c-k=1&X=Y-Z-m&11=1b");13.1x(z)}C
1b(Q){1c=Q.R.24[0];6 1y=1c.1z.$t.F(0,19)+1c.1z.$t.F(23,25);6
1d=26(1y);4(i=="o"){6 1e="/r?S-c="+1d+"&c-k="+j+"#G="+I}b{6
1e="/r/s/"+n+"?S-c="+1d+"&c-k="+j+"#G="+I}27.9=1e}',62,132,'|||span|if|html|var|class||href||else|max|maksimal|indexOf|nomerhal|showpageNum|thisUrl|jenis|postperpage|results|jj|script|lblname1|page|||search|label||urlactivepage|onclick|return|false|document|newInclude|mulai|home_page|function|akhir|pageArea|substring|PageNo|numberpage|nopage|nomerkiri|parseInt|redirectpage|redirectlabel|numshowpage|upPageWord|length|root|feed|updated|src|feeds|posts|summary|alt|json|in||callback|jsonstart|nBody||banyakdata|prevnomer|nextnomer|blogPager||hitungtotaldata|finddatepost|post|timestamp|alamat|halamanblogger|loophalaman|for|downPageWord|div|farhan|innerHTML|totaldata|write|getElementsByTagName|head|createElement|type|text|javascript|setAttribute|start|index|appendChild|timestamp1|published|showpageOf|Page|of|showpage|showpagePoint|http|www|abu|com|style|font|size|7pt|float|right|margin|10px|target|_blank|Widget|by|Abu|getElementsByName|getElementById|blog|pager||openSearch|totalResults||entry|29|encodeURIComponent|location'.split('|'),0,{}))
//]]> if (window.jstiming) window.jstiming.load.tick('widgetJsBefore'); if
(typeof(BLOG_attachCsiOnload) != 'undefined' && BLOG_attachCsiOnload != null) {
window['blogger_templates_experiment_id'] =
"templatesV1";window['blogger_blog_id'] =
'985826546147455418';BLOG_attachCsiOnload('archive_');
}_WidgetManager._Init('//www.blogger.com/rearrange?blogID\x3d985826546147455418','//aids-hivdisease.blogspot.com/2011_04_01_archive.html','985826546147455418');
_WidgetManager._SetDataContext([{'name': 'blog', 'data': {'blogId':
'985826546147455418', 'bloggerUrl': 'http://www.blogger.com', 'title': 'Aids-Hiv',
'pageType': 'archive', 'url':
'http://aids-hivdisease.blogspot.com/2011_04_01_archive.html', 'canonicalUrl':
'http://aids-hivdisease.blogspot.com/2011_04_01_archive.html',
'canonicalHomepageUrl': 'http://aids-hivdisease.blogspot.com/', 'homepageUrl':
'http://aids-hivdisease.blogspot.com/', 'blogspotFaviconUrl':
'http://aids-hivdisease.blogspot.com/favicon.ico',
'enabledCommentProfileImages': true, 'adultContent': false, 'disableAdSenseWidget':
false, 'analyticsAccountNumber': '', 'searchLabel': '', 'searchQuery': '', 'pageName':
'April 2011', 'pageTitle': 'Aids-Hiv: April 2011', 'encoding': 'UTF-8', 'locale':
'en-GB', 'isPrivate': false, 'isMobile': false, 'isMobileRequest': false,
'mobileClass': '', 'isPrivateBlog': false, 'languageDirection': 'ltr', 'feedLinks':
'\74link rel\75\42alternate\42 type\75\42application/atom+xml\42
title\75\42Aids-Hiv - Atom\42
href\75\42http://aids-hivdisease.blogspot.com/feeds/posts/default\42
/\76\n\74link rel\75\42alternate\42 type\75\42application/rss+xml\42
title\75\42Aids-Hiv - RSS\42
href\75\42http://aids-hivdisease.blogspot.com/feeds/posts/default?alt\75rss\42
/\76\n\74link rel\75\42service.post\42 type\75\42application/atom+xml\42
title\75\42Aids-Hiv - Atom\42
href\75\42http://www.blogger.com/feeds/985826546147455418/posts/default\42
/\76\n\74link rel\75\42EditURI\42 type\75\42application/rsd+xml\42
title\75\42RSD\42
href\75\42http://www.blogger.com/rsd.g?blogID\75985826546147455418\42 /\076',
'meTag': '', 'openIdOpTag': '', 'imageSrcTag': '', 'latencyHeadScript': '\74script
type\75\42text/javascript\42\76(function() { var
a\75window,b\75\42jstiming\42,d\75\42tick\42;var
e\75function(c){this.t\75{};this.tick\75function(c,p,h){h\75void 0!\75h?h:(new
Date).getTime();this.t[c]\75[h,p]};this[d](\42start\42,null,c)},f\75new
e;a.jstiming\75{Timer:e,load:f};if(a.performance\46\46a.performance.timing){var
g\75a.performance.timing,j\75a[b].load,k\75g.navigationStart,l\75g.responseStart;0\74k\46\46l\76\75k\46\46(j[d](\42_wtsrt\42,void
0,k),j[d](\42wtsrt_\42,\42_wtsrt\42,l),j[d](\42tbsd_\42,\42wtsrt_\42))}\ntry{var
m\75null;a.chrome\46\46a.chrome.csi\46\46(m\75Math.floor(a.chrome.csi().pageT),j\46\0460\74k\46\46(j[d](\42_tbnd\42,void
0,a.chrome.csi().startE),j[d](\42tbnd_\42,\42_tbnd\42,k)));null\75\75m\46\46a.gtbExternal\46\46(m\75a.gtbExternal.pageT());null\75\75m\46\46a.external\46\46(m\75a.external.pageT,j\46\0460\74k\46\46(j[d](\42_tbnd\42,void
0,a.external.startE),j[d](\42tbnd_\42,\42_tbnd\42,k)));m\46\46(a[b].pt\75m)}catch(n){};a.tickAboveFold\75function(c){var
i\0750;if(c.offsetParent){do
i+\75c.offsetTop;while(c\75c.offsetParent)}c\75i;750\76\75c\46\46a[b].load[d](\42aft\42)};var
q\75!1;function
r(){q||(q\75!0,a[b].load[d](\42firstScrollTime\42))}a.addEventListener?a.addEventListener(\42scroll\42,r,!1):a.attachEvent(\42onscroll\42,r);\n
})();\74/script\076', 'mobileHeadScript': '', 'adsenseClientId':
'pub-9292059858425752', 'view': '', 'dynamicViewsCommentsSrc':
'//www.blogblog.com/dynamicviews/4224c15c4e7c9321/js/comments.js',
'dynamicViewsScriptSrc': '//www.blogblog.com/dynamicviews/04452fcc9c8aa994'}},
{'name': 'skin', 'data': {'vars': {'sidebartextcolor': '#666666', 'linkcolor':
'#5588aa', 'visitedlinkcolor': '#999999', 'textcolor': '#333333', 'headerfont':
'normal normal 78% \47Trebuchet MS\47,Trebuchet,Arial,Verdana,Sans-serif',
'pagetitlefont': 'normal normal 200% Georgia, Serif', 'bgcolor': '#ffffff',
'descriptioncolor': '#999999', 'titlecolor': '#cc6600', 'bordercolor': '#cccccc',
'postfooterfont': 'normal normal 78% \47Trebuchet MS\47, Trebuchet, Arial, Verdana,
Sans-serif', 'pagetitlecolor': '#666666', 'bodyfont': 'normal normal 100% Georgia,
Serif', 'endSide': 'right', 'startSide': 'left', 'descriptionfont': 'normal normal 78%
\47Trebuchet MS\47, Trebuchet, Arial, Verdana, Sans-serif', 'sidebarcolor':
'#999999'}, 'override': ''}}, {'name': 'view', 'data': {'classic': {'name': 'classic',
'url': '/?view\75classic'}, 'flipcard': {'name': 'flipcard', 'url':
'/?view\75flipcard'}, 'magazine': {'name': 'magazine', 'url': '/?view\75magazine'},
'mosaic': {'name': 'mosaic', 'url': '/?view\75mosaic'}, 'sidebar': {'name': 'sidebar',
'url': '/?view\75sidebar'}, 'snapshot': {'name': 'snapshot', 'url':
'/?view\75snapshot'}, 'timeslide': {'name': 'timeslide', 'url':
'/?view\75timeslide'}}}]); _WidgetManager._RegisterWidget('_HTMLView', new
_WidgetInfo('HTML2', 'sidebar', null, document.getElementById('HTML2'), {},
'displayModeFull')); _WidgetManager._RegisterWidget('_HTMLView', new
_WidgetInfo('HTML1', 'sidebar', null, document.getElementById('HTML1'), {},
'displayModeFull')); _WidgetManager._RegisterWidget('_PopularPostsView', new
_WidgetInfo('PopularPosts1', 'sidebar', null,
document.getElementById('PopularPosts1'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_LabelView', new _WidgetInfo('Label1', 'sidebar',
null, document.getElementById('Label1'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_BlogArchiveView', new
_WidgetInfo('BlogArchive1', 'sidebar', null,
document.getElementById('BlogArchive1'), {'languageDirection': 'ltr'},
'displayModeFull')); _WidgetManager._RegisterWidget('_HeaderView', new
_WidgetInfo('Header1', 'header', null, document.getElementById('Header1'), {},
'displayModeFull')); _WidgetManager._RegisterWidget('_NavbarView', new
_WidgetInfo('Navbar1', 'navbar', null, document.getElementById('Navbar1'), {},
'displayModeFull')); _WidgetManager._RegisterWidget('_BlogView', new
_WidgetInfo('Blog1', 'main', null, document.getElementById('Blog1'),
{'cmtInteractionsEnabled': false, 'lightboxEnabled': true, 'lightboxModuleUrl':
'//www.blogger.com/static/v1/jsbin/3811339452-lbx_en-GB.js', 'lightboxCssUrl':
'//www.blogger.com/static/v1/v-css/228702327-lightbox_bundle.css'},
'displayModeFull')); _WidgetManager._RegisterWidget('_HTMLView', new
_WidgetInfo('HTML6', 'main', null, document.getElementById('HTML6'), {},
'displayModeFull'));

